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This study was designed to determine whether kefir accentuates the positive health 
benefits assessed by measures in fitness and/or body composition, as a measure of 
cardiovascular disease risk as well as the biomarker c-reactive protein.  Sixty-seven adult 
males and females aged 18-35 years were assigned to one of four groups: 1) endurance 
training  + control beverage, 2) endurance training + kefir beverage, 3) active control + 
control beverage or 4) active control  + kefir beverage.  The exercise groups completed 
15 weeks of structured endurance training while the active control groups maintained 
their usual exercise routine.  Baseline physiological and exercise measurements were 
collected pre-intervention and post-intervention. Blood and saliva samples were analyzed 
for C-reactive protein, tumor necrosis factor-alpha and secretory immunoglobulin A. 
Instances of sickness and illness throughout the intervention were also examined. 
Additionally, each group was assigned to either a kefir or a calorie/macronutrient 
matched placebo beverage that was consumed twice per week.  The endurance training 
protocol was effective as demonstrated by a significant improvement (p<0.05) in the 1.5-
mile times of the endurance training groups.  The endurance training groups also 
experienced a significantly higher (p<0.05) number of sicknesses than the active control 
groups. There were no significant interactions among groups with respect to 
physiological outcome variables with the exception of serum C-reactive protein.  The 
endurance training group receiving a control beverage demonstrated a significant increase 
(p<0.05) in C-reactive protein following the 15 week training program while the 
endurance training group receiving a kefir beverage had no significant change in C-
reactive protein.  Although the reported sickness was not significantly different between 
x 
 
the endurance training group + kefir beverage and the endurance training group + control 
beverage, kefir supplementation may have been a factor in attenuating the increase in C-
reactive protein that was observed over the course of the intervention period.  This 
preliminary study suggests that kefir may be involved in improving the risk profile for  
cardiovascular disease as defined by C-reactive protein.
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CHAPTER 1.  INTRODUCTION 
1.1 Fermented Milk: History and Principles 
 Evidence of fermented milk production dates back to 7000 BCE with origins in 
the middle and far-east of Asia, making it one of the oldest methods of both temporary 
and long term food preservation. A further spreading east of these traditions, by way of 
Russia and Eastern Europe, by the Tartars, Mongols and Huns occurred during the 
expansion and conquests by these empires (Vasiljevic, et. al., 2008).   The expansion of 
cultures that maintained livestock as a source of meat and dairy foods by the introduction 
of herds and traditional production methods, and subsequent industrialization of dairy 
food production, has led to a total worldwide domestic ruminant population of nearly 
three billion at the beginning of the twenty-first century (Weimer, 2001).   
 Cultures that were traditionally associated with herding or keeping livestock, 
including cattle, sheep, goats, mares or water buffalo, discovered and, over the course of 
many generations, refined the process of milk preservation. This ultimately led to the 
wide the range of fermented milks produced today, which are as diverse as the cultures 
that produce them.  From the traditional sour milks of Eastern Europe to the hard salty 
cheeses first developed throughout the Mediterranean region, cultured dairy products 
have been a dietary staple for humans throughout recorded history, and although unaware 
of the microbiological processes involved, traditions and protocols were established 
within herding communities that ensured the methodologies and knowledge required to 
produce the flavors and textures associated with specific fermented dairy products were 
kept intact.  Often, these practices were passed down from generation to generation 
within local communities, feudal states and monasteries (Caplice, et. al., 1999).  Over 
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time, the tastes associated with fermented milks, such as the characteristic acidic flavor, 
may have also become associated with increased health and longevity, thus furthering its 
spread and increasing manufacture throughout and within ancient populations.  
 It was not until the late nineteenth century that scientists first began to take note 
that there were factors present in fermented milks that may be providing health benefits 
to the consumer that were beyond the scope of non-fermented milk.  This realization 
sparked early microbiological work involving milk and fermented food products by 
numerous scientists, including Nobel Laureate Elie Metchnikoff, who correlated a large 
consumption of fermented milk to an above average life span.  In populations of 
Bulgarian peasants consuming ‘sour milk’, he noticed that the average life span was 
eighty-seven years old, with one out of four living past one hundred years of age 
(Vasiljevic, 2008).  Following suit, scientists such as Grigoroff (1905) and Rettger, et. al. 
(1914), as well as Metchnikoff himself (1905) were isolating bacteria from fermented 
milks and demonstrating that certain strains could survive and colonize the intestinal tract 
 Fermentation is defined as the conversion of carbohydrates to organic acids or 
alcohol and carbon dioxide, using bacteria and yeasts, or a combination thereof, under 
anaerobic conditions (Kosikowski, et. al., 1999).  In milk, these fermentations most often 
occur as a result of the hydrolysis of lactose by lactic acid bacteria containing the enzyme 
β-galactosidase.  Lactic acid bacteria prefer lactose as their source of carbon, and the end 
products can be exclusively lactic acid or a combination of lactic acid and other 
metabolic end products, such as acetic acid, carbon dioxide and hydrogen (Alfa-Laval, 
1987).  Yeasts, such as Saccharomyces cerevisiae, are also capable of fermenting lactose 
and other sugars and can be found in some fermented milks (Kwak, et. al., 1996).  The 
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steps involved in the fermentation of glucose by lactic acid bacteria and yeasts are 
outlined in Figure 1. 
Glucose 
                                                       Glycolysis 
2 pyruvic acids 
   Lactic acid fermentation                                                       Alcoholic fermentation 
                                                            2 acetalaldehydes 
 
2 lactic acids                                        2 ethanols 
Figure 1.  Lactic acid fermentation and alcoholic fermentation. 
  
 It also important to note that while the production of lactic acid from the 
fermentation of lactose contributes to the characteristic acidity associated with fermented 
milks, many interesting parallel post fermentation reactions often occur with other 
substrates, such as peptones, peptides and fatty acids to produce some of the distinctive 
flavors associated with cultured products. 
1.2 Kefir Definition and Origin 
 Due to a growing consumer awareness and demand for foods with added or 
naturally occurring probiotics, a fermented milk called “kefir” is gaining in popularity 
and commercial production of kefir-like products has greatly increased over the past 
several years.  Kefir is a naturally fermented milk beverage with a smooth and creamy 
texture and has an acidic and slightly alcoholic and yeasty taste; the presence of carbon 
dioxide gives a varying degree of effervescence (Farnsworth, 1999).  In fact, the word 
kefir is derived from the Turkish word ‘kef’, which means pleasant taste (Kurmann, et. 
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al., 1992).   Kefir originated in the Caucasus Mountains several centuries ago and was 
traditionally produced with caprine milk by inhabitants closely associated with the 
herding of goats and sheep.   
 Kefir has a rich history as it pertains to its genesis and spread throughout the 
regions of the Balkan and Caucasus regions of Eastern Europe; in fact, the origins of kefir 
predate written records (Rosell, 1932).  Because of its ancient and apparently mysterious 
origin, kefir was known in antiquity as the ‘Drink of the Prophet [Mohammad]’ and the 
culture used to prepare it as the ‘Grains of the Prophet Mohammad’.  It was believed that 
the Prophet of Islam, Mohammad, was given the original kefir grains by the Angel 
Gabriel to be given to his followers, thus introducing kefir to the Orthodox Christians 
living in the mountainous regions of modern day Georgia (Margulis, 1996).  A recent 
study by Yang, et. al. (2015) presented direct proteomic evidence for production of kefir 
that was found as an organic mass associated with the mummies of an Early Bronze Age 
(1980–1450 BCE) cemetery in Xinjiang, China. 
1.3 Kefir Starter Culture 
 Kefir differs from other fermented milk products in its unique starter culture, which 
is an aggregation of many different bacteria and yeast species bound together in an 
exopolysaccharide (EPS) matrix produced by certain lactic acid bacteria in the presence of 
yeast (Figure 2).  Farnsworth (1999) describes kefir grains as a mass of bacteria, yeasts, 
polysaccharides, and other products of bacterial metabolism, together with curds of milk 
proteins. The starter cultures, termed “grains”, grow, propagate and pass their properties 





Figure 2.  Macroscopic structure of kefir grains. (source: De Oliveira Leite, et. al., 2013: 
Creative Commons License CC BY-NC) 
  
 When describing the perpetuation of kefir grains by certain groups throughout 
history Rosell (1932) said, “One of the things that puzzle investigators in regard to the 
preparation of these milks [kefir] is that most of the races named are those who have kept 
kefir in its pure form.  The method of their preparation was handed down as a precious 
inheritance from father to son in the families who concerned themselves with these 
products of ancient lineage, which, in a certain sense, may be said to constitute the ‘secret 
medicine’ of many countries.”  It is the production of kefir and the propagation of the 
starter culture, using the traditional methods that preserve its defining characteristics, which 
have remained intact due to the preservation of the complex diversity and delicate balance 
of the microbial communities of the grains.      
 The fermentation of fresh milk is accomplished by the addition of the kefir grains, 
which may contain up to 50 bacterial species from genera including lactobacilli, lactococci, 
leuconostocs, acetobacter, enterococci and micrococci and up to 30 different yeast species 
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from genera such as kluvermyces and sacromyces; the strains are bound together by the 
exopolysaccharide kefiran, which is produced by the bacterial species Lactobacillus 
kefiranofaciens (Kwak, et. al., 1996; Diosma, et. al., 2014; Garofalo, et. al., 2015).  The 
yellowish, white structures resemble small cauliflower florets and have a firm gel texture; 
the average kefir grain is approximately the size of a small marble with a weight of 0.5-1.5 
grams (g), although individual grains can vary greatly in size and shape.  The grains 
typically range in size from 0.3 to 3.5 centimeters (cm) in diameter; however some grains 
have been reported to grow much larger (Garrote, et. al., 1997).  They are insoluble in 
water and ordinary solvents, and when immersed in milk the grains initiate the dual lactic 
acid and alcohol fermentations (Kosikowski, et. al., 1999).  Zourari, et. al. (1988) reports 
the chemical composition of kefir grains as 890-900 grams/kilogram (g/kg) water, 2 g/kg 
lipid, 30 g/kg protein, 60 g/kg sugars and 7 g/kg ash.  
 Fermentation of milk with the kefir grains proceeds for approximately 24 hours. 
An initial drop in the pH is caused by the rapid growth of heterofermentative streptococci 
bacteria; the lowered pH favors the growth of lactobacilli, but causes the streptococci 
numbers to decline.  The presence of yeasts in the kefir grains, along with the 
fermentation temperature (approximately 25°C) encourages the growth of aroma-
producing heterofermentative streptococci.  During the final stages of the initial 
incubation and during subsequent storage, growth of lactic acid bacteria is favored over 
growth of yeasts and acetic acid bacteria (Farnsworth, 2003 and Koroleva, 1988). 
 The microflora of kefir grains is remarkably stable, retaining its activity for years 
if preserved and incubated under the necessary physiological conditions required for the 
continued propagation the probiotic species (Simova, et. al., 2002).  According to 
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Garrote, et. al. (1997), wet kefir grains will only retain activity for only 8-10 days if not 
inoculated into fresh milk, while dried grains retain activity for 12-18 months.  
 Studies have shown that grains from different geographic regions vary widely in 
composition, which can result in large variance in the finished kefir products (Marshall, et. 
al., 1984; Pintado, et. al., 1996; Simova, et. al., 2002; Wang, et. al., 2008).  In addition, the 
microbiologic study of kefir is complicated by the constant evolution of identification and 
the related nomenclature of bacteria, often causing difficulties when comparing data 
between labs or with previous reports (Farnsworth, 1999).   
 In studies using electron microscopy to examine the structure and composition of 
kefir grains, Bottazzi, et. al. (1980) suggested that the yeasts and lactobacilli are not 
randomly distributed in the grain; the lactobacilli were associated with the periphery of the 
grain and the majority of yeasts located inside the grain.  The source of the kefir grains for 
this study were only identified as “obtained from a commercial source”, which may pose 
problems as grains from various regions may vary structurally in terms of distribution of 
the microflora as the species present varies between grains sourced from different 
sources/regions.  In a 2005 study examining the microflora of Turkish kefir grains, Guzel-
Seydem, et.al. found a ratio of 109:106 of lactic acid bacteria and yeasts, with lactobacilli 
species predominating, and no significant fluctuation during storage.  However, previous 
studies on Irish kefir grains, performed by Rea, et. al. (1996) showed the contents of grains, 
reported in colony forming units per milliliter (cfu/ml) of lyophilized sample, to be 109 





Table 1.  Average number of colony-forming units (CFUs) of probiotic microorganisms 
found in 1 gram (g) of traditionally produced kefir. 







   100,000,000 
       5,000,000 
       1,000,000 
         100,000 
     (adapted from: Guzel-Seydem, et.al., 2005) 
  
 The weight percentage of kefir grains used to inoculate the milk has been shown 
to have a significant effect on the numbers of different microorganisms found in the 
finished product.  When using a 1% by milk weight ratio of grains, lactobacilli and 
lactococci levels were found at the highest levels at the end of a 30 day storage period; 
when a 5% inoculate was used yeasts and acetic acid counts were highest after 72 hours 
(Irigoyen, et. al., 2005).  Similarly, results by Koroleva (1988) demonstrated that the 
number of lactic acid bacteria tended to increase over time when lesser amounts of kefir 
grains were inoculated into the milk.  
1.3.1 Microflora 
 Isolation and identification of the different strains of bacteria and yeasts present in 
kefir grains have traditionally been performed using culture-dependent methods, meaning 
that the probiotic species must be grown on selective media with identification being based 
on morphological and biochemical characteristics (Simova, et. al., 2002 and Wang, et. al.,  
2008).  However, some studies have shown that many of the strains are very closely related 
and may pose problems when trying to isolate and identify individual strains (Micheli, et. 
al., 1999; Guzel-Seydim, et. al., 2005).   More recent investigations have attempted to 
isolate strains based on genotype using polymerase chain reaction (PCR) combined with 
denaturing gradient gel electrophoresis (DGGE) (Wang, et. al., 2008; Tas, et. al., 2012; 
Garofalo, et. al. 2015).  This culture-independent identification may be a useful in 
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analyzing complex microbial populations because this type of testing does not require prior 
separation of individual strains, as in culture-dependent identifications (Ercolini, 2004).  
1.3.1.1 Lactobacilli 
 Lactobacilli are present in the largest amounts (65-85%) of the microbial population 
of kefir and kefir grains (Witthuhn, et. al., 2004).  In a study examining the microflora of 
Brazilian kefir and kefir grains, Magalhas, et. al. (2011) also found lactobacilli species to 
be the predominant lactic acid bacteria type (78%) in kefir fermented with kefir grains, 
with lactococci comprising the majority of the remaining 28% of lactic acid species.  
Magalhas, et.al. (2011) also identified lactic acid bacteria isolates; Lactobacillus paracasei 
represented the largest and most commonly identified lactic acid bacteria isolate which 
represented 89 of 249 isolates.  This was followed by Lactobacilli parabuchneri (41 
isolates), Lactobacilli casei (32 isolates) and Lactobacilli kefiri (31 isolates) (see Table 2).
Table 2.  Bacterial species commonly found in kefir and kefir grains. 
Lactobacilli                                                                                    Lactococci Acetic Acid Bacteria 
Lactobacillus kefir Lactococcus lactis subsp. lactis Acetobacter aceti 
Lactobacillus kefiranofaciens Lactococcus lactis subsp. cremoris Acetobacter pasteurians 
Lactobacillus rhamnosus 
	   	  Lactobacillus casei Streptococci	   Other Bacteria	  
Lactobacillus paracasei Streptococci thermophilus	   Bacillus subtilis	  




Lactobacillus fermentum Leuconostocs	  
Lactobacillus viridescens Leuconostoc mesenteroides	  
Lactobacillus helveticus Leuconostoc kefir	  





Lactobacilli parabuchneri  
Lactobacilli kefiri 
 
       (adapted from: Witthuhn, et. al., 2004; Guzel-Seydim, et. al., 2005; Wang, et. al., 2008;  





1.3.1.2 Lactococci  
 Magalhas, et. al. (2011) was only able to isolate one species, Lactococcus lactis, 
from Brazilian kefir and kefir grains; this particular species was identified in all 24 
lactococci isolates from the total of 249 lactic acid bacteria isolates.  In a 2005 study by 
Guzel-Seydim, et. al. a microbial enumeration and electron microscopy was performed on 
Turkish kefir and kefir grains, and although long, short and curved lactobacilli and yeasts 
were found in all samples, lactococci were not observed in any portion of the kefir grain.  
Guzel-Seydim, et. al. (2005) postulated that the presence of lactococci in the kefir but not 
in the grain samples might be caused by the unintentional removal of lactococci from the 
surface of the grains.   
1.3.1.3 Yeasts 
 Magalhas, et. al. (2011) showed a majority of Brazilian kefir yeast isolates to be 
lactose-negative strains; specifically Saccharomyces cerevisiae, which made up 41 of 110 
yeast isolates.  Other non-lactose fermenting species isolated included Kazachstania 
aerobia (23 isolates) and Lachancea meyersii (15 isolates); these two species had been 
previously unreported in kefir and kefir grain studies (see Table 3). Yeasts, such as 
Saccharomyces cerevisae, contribute greatly to the sensory qualities of the kefir 
beverage, as they promote an alcoholic and yeasty aroma, as well as a refreshing taste 
(Magalhaes, et. al., 2011).  It is also worth noting that the presence of non-lactose 
fermenting yeasts in kefir and kefir grains is dependent on the presence of other lactose 
































 Kluyveromyces marxianus 
Kluyveromyces lactis   
    
 
 (adapted from: Simova, et. al., 2002; Magalhaes, et. al., 2011; Diosma, et. al., 2014; 
   Garofalo, et. al., 2015)  
  
 According to Irigoyen, et. al. (2005), the levels of yeasts and acetic acid bacteria 
present in kefir are directly proportional to the quantity of grains inoculated.  Interestingly, 
their study also found the levels of lactobacilli and lactococci to be inversely proportional 
to the amount of inoculate used; therefore, the number of microorganisms was higher when 
fewer kefir grains were used.  This might be due to a more rapid initial increase in the 
amount of lactic acid bacteria in the kefir inoculated with the higher percentage of grains; 
the higher number of initial bacteria might cause a quick, sharp drop in pH which would 
kill some of the more acid sensitive strains, thus preventing their growth during storage and 
allowing for an increased proliferation over time of yeasts and other types of bacteria, such 
as micrococci and acetic acid bacteria.  It has also been shown that lactic acid bacteria 
multiply less rapidly, and therefore, produce lactic and acetic acids more slowly when 
incorporated into a mixture containing yeasts than in a pure culture (Collar, 1996).             
       During refrigerated storage of kefir, lactic acid bacteria will begin to decrease, while 
the numbers of yeasts and acetic acid bacteria will remain fairly consistent (Irigoyen, et. 
al., 2005).  Irigoyen, et. al. (2005) found no significant differences in yeast counts during 
a thirty day storage period at approximately 5°C; however, lactobacilli and lactococci 
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were shown to be significantly lower after thirty days of storage.  These results differ 
from a similar study by Guzel-Seydim, et. al. (2005) that examined the microbiota of 
Turkish kefir and kefir grains; the microbial counts of the lactic acid bacteria did not 
decrease, and actually exhibited continued growth during and after 21 days of 
refrigerated storage.  This can most likely be attributed to the ability of many of the yeast 
species present in kefir to metabolize some of the lactic acid produced by the bacteria, 
therefore enhancing the survivability of the lactic acid bacteria by the reduction metabolic 
end products. 
1.3.2 Kefiran 
       EPS produced by some lactic acid bacteria have been the recent focus of research in 
various food industries as a beneficial additive for increasing viscosity in products, and the 
stipulated health benefits associated with bacterial EPS provide an added appeal to the 
consumer.  Kefiran, an EPS produced and subsequently excreted by a certain strains of 
lactic acid producing bacteria found in kefir grains and kefir has been isolated, and its 
composition and chemical structure have been determined using methods such as acid and 
enzymatic hydrolysis and scanning electron microscopy (Figure 3).   Although, at present, 
no studies isolating kefiran from the kefir beverage have been reported, Cerning, et. al. 
(1999) listed the range amount of EPS produced by lactic acid bacteria in fermented 




Figure 3.  Scanning electron microscopy of Brazilian kefir grain microbiota. A, C, E: outer 
grain portions, B, D, F: inner grain portions. Arrows - Micrography A: cocci; Micrography 
D: fibrillar material - kefiran polysaccharide; Micrography E: arrow 1 - granular material - 
coagulated protein, arrow 2 - different yeast species. (source: De Oliveira Leite, et. al., 
2013: Creative Commons License CC BY-NC) 
 
       The structure of kefiran was described by Riviere, et. al. (1967) as a water-soluble 
glucogalactan containing roughly equal amount of D-glucose and D-galactose residues. 
The production of this EPS is stimulated when L. kefiranofaciens grows in co-culture 
with S. cerevisiae, other yeasts and yeast extracts (Cheirsilp et al., 2003; Zajšek, et. al., 
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2013; Pop, et. al., 2014). Lactobacillus kefiranofacians, the kefiran producing strain, 
comprises at least 24% of the dry material of the kefir grain.  Although the chemical 
analysis preformed by Riviere, et. al. (1967) was accurate, the bacterium has, in recent 
years, been referred to as Lactobacillus kefir (Frengova, et, al., 2002) and most currently 
asLactobacillus kefiranofacians (Cheirsilp, et. al., 2003).  However, there are conflicting 
opinions in several independent studies regarding the naming of this bacterium and if the 
Lactobacillus kefiran and Lactobacillus kefiranofacians are the same strain or two 
different strains, with one or both producing kefiran in differing amounts (Kandler, et. al., 
1983; Frengova, et. al., 2002; Rimada, et. al., 2002; Piermaria, et. al., 2009). 
 Different conditions such as the species present, the ratio of bacteria to yeasts, 
fermentation time, incubation temperature, storage time and other conditions can all 
affect the amount of EPS produced by kefiran producing strains (van Geel-Shutten, et. 
al., 1998).  Mozzi, et. al. (1995) found that by increasing the time of fermentation up to 
72 hours a significant reduction in kefiran synthesis was observed; these results were 
dependent both on the fermentation temperature (30, 37 and 42°C) and the strain of lactic 
acid bacteria employed.   
 The activity of the grains, or more precisely, the activity of the kefiran producing 
strains also plays a major role in the amount of kefiran present in the product.  Schoevers, 
et. al. (2003) has reported a lowering of lactobacilli species present, as well as cellular 
activity, in some the kefir grains that have been subjected to prolonged storage without 
fresh milk or exposure to widely varying environmental conditions, such as fluctuating 
incubation temperatures or a change in milk type.  
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 Because other environmental conditions such as temperature, pH, carbon and 
nitrogen content influence EPS production, control of fermentation protocols are 
important.  Zajšek, et. al. (2013) established the optimal fermentation temperature to be 
30°C, where EPS production from the kefir grains was maximal. Some yeast species 
present are also able to metabolize some of the lactic acid produced by the bacteria, 
therefore enhancing the survivability of the lactic acid bacteria by the reduction metabolic 
end products.  EPS similar to kefiran have also been isolated, although in lesser amounts, 
from other lactic acid species such as Lactobacillus reuteri and Lactococcus lactis ssp. 
cremoris (van-Geel Schutten, et. al., 1998; Yang, et. al., 1999; Patel, et. al., 2012).  Other 
examples of EPS use in the food industry are xanthan produced by Xanthomonas 
campestris and gellan from Pseudomonas eloda (Matsukawa, et. al., 2007; Patel, et. al., 
2012).    
1.4 Physiochemical and Sensory Properties of Kefir 
 The major end products, according to Kooman (1968), are approximately 0.8% 
lactic acid, 1.0% ethyl alcohol and carbon dioxide.  Also present in smaller amounts are 
acetic acid, numerous volatile flavor compounds such as diacetyl and acetylaldehyde, 
exopolysaccharides, organic acids, and various vitamins and minerals.  The optimum taste 
profile in kefir has a 3:1 diacetyl to acetylaldehyde ratio with a pH of 4.6 using milk with 
an initial fat content of no less than 3.0%, and although complex alcohols and acetone have 
also been identified as end products, they are not thought to be predominant factors in the 
flavor profile (Kosikowski, et. al., 1997; Kakisu, et. al., 2011).   
 The fat content of kefir may range from 0.5 to 3.0 percent, with solids not from 
fat from 8.0 to 11.0 percent (Kosikowski, et. al., 1999).  This includes approximately    
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2.0 g of lactose per 100 g of kefir; the fermentation of milk by kefir grains results in 
approximately a 30% reduction in lactose (Alm, 1980).  Alm (1980) examined lactose 
intolerant individuals demonstrating symptoms of abdominal distress and diarrhea 
following consumption of 500 ml of low fat milk and found that of the same quantity of 
fermented milk did not result in any symptoms.  
 The fat content of kefir will vary depending on the original fat content of the milk 
used (whole vs. skim, bovine vs. caprine), and the action of the microflora on milk fat can 
have significant effects on the lipid profile, especially after storage for a brief period 
(Gul, et. al., 2015).  In a study involving the physiochemical analysis of milk, Irigoyen, 
et. al. (2005) found that the fat content of the finished kefir did not differ significantly 
from the fat content of the milk that the kefir was made from; however, oxidation of the 
fat molecules and the off-flavors associated with lipid oxidation can be counteracted to 
some degree by the microorganisms in kefir (as well as other fermented milks).  The 
lactic acid bacteria consume oxygen providing a reducing effect, and during storage 
lipolysis, the breakdown of fats into glycerol and free fatty acids will also occur, 
contributing to an increase in short chain fatty acids (SCFA) (Alfa-Lavel, 1987).   
 Flavors attributed to higher levels of SCFA in milk can be very influential on 
flavor profile of fermented milks. For example, the release of capric acid, the most 
abundant saturated fatty acid found in goat milk, from the triglyceride will result in a 
distinctive goat milk flavor, often characterized as a “goaty” or “musky” flavor. The 
yeasts involved in kefir fermentation, particularly Saccharomyces cerevisiae, are also of 
importance when characterizing the sensory qualities of the kefir beverage, as they 
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promote a strong and typically yeasty aroma, as well as a refreshing and pungent, slightly 
alcoholic taste (Magahlaes, et. al., 2010).   
1.5 Kefir Production Methods and Consumer Preferences 
 During kefir manufacture with the grains, the lactic acid fermentation slows 
considerably or stops as the pH declines, but the yeast fermentations continue allowing 
for an increase in ethanol production during storage. The secondary alcohol fermentations 
can lead to substantial changes in flavor as well as bulging or leaking packaging due to 
the continued production of carbon dioxide gas (Kwak, et. al., 1996; Sarkar, 2008). 
 Commercial kefir production utilizes a dry starter culture typically consisting of 
8-12 species of bacteria and yeasts isolated from lyophilized kefir grains (or other 
sources).   A new commercial starter, whether dry or from a liquid mother culture, must 
be added to each new batch of milk for kefir production.  Studies preformed by Simova, 
et. al. (2002) demonstrated that traditionally produced kefir (with the starter grains 
removed) could not be used as a starter culture for kefir.   The primary drawbackfor the 
large scale manufacture and marketing of traditionally produced kefir is that secondary 
alcohol fermentation often occurs at the distribution and storage phases, resulting in 
changes in flavor and taste because of the continued formation of ethanol and carbon 
dioxide gas (Kwak, et. al., 1996).  This can result in swollen and leaking containers as the 
excess gas increases the internal pressure of the container and inconsistences in the final 
products. 
 A study by Beshkova, et. al. (2002) showed and increase in ethanol from 0.25% in 
traditional to 0.48% in commercial kefir, and an increase in CO2 of 1.05g/l to 1.98 g/l.  
Kwak, et. al. showed that biostabilization of kefir can be achieved by using a starter 
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culture in which non-lactose fermenting yeasts, such as Saccharomyces cerevisiae, are 
present in substantial numbers.   In fact, the standardization of the production of flavor 
compounds including lactic acid and ethanol has been achieved, for the most part, by the 
utilization of pure cultures as a starter for the commercial production of kefir.  
Gronnevik, et. al. (2011) showed that the levels of lactic acid and ethanol in Norwegian 
commercial kefir remained consistent during an 8-week storage period, with some 
volatile compounds fluctuating slightly; this was probably due to an increase in the yeast 
metabolism of bacterial intermediate or end products.  This can be compared to studies 
performed on the physicochemical changes in milk during the production and storage of 
traditional kefir, which were found to be in flux and somewhat inconsistent between kefir 
made from differently sourced grains (Wszolek, et. al., 2001; Chen, et. al., 2005; 
Irigoyen, et. al., 2005; Magalhaes, et. al., 2011). The development of commercial starter 
cultures has allowed for widespread distribution of kefir and kefir products; however, the 
demand for traditionally produced kefir is rising, and methods for producing a consistent 
product with an adequate shelf life are being developed.  
1.6 Health Benefits of Probiotics and Kefir 
 Similar to other fermented dairy foods supplemented with probiotic bacteria, 
health aspects attributed to the consumption of kefir include, but are not limited to, 
improved lactose utilization, anti-carcinogenic activity, control of intestinal infections 




Figure 4.  Proposed health benefits associated with the consumption of probiotics. 
(source: Anandharaj et al., 2014; distributed under the Creative Commons Attribution 
License) 
   
 In order for a probiotic to benefit human health it must have good technological 
properties, survive through the upper gastrointestinal tract and be able to function in the 
gut environment (Mattila-Sandholm, et. al., 2002).  These properties, as well as many 
health benefits, have been examined, and kefir has demonstrated a wide array of positive 
effects such as antitumor and immunostimulating activity in animals (Quiros, et. al., 
2005; Ghoneum and Gimzewski, 2014); these effects are only seen when the probiotics 
ingested are functioning properly in the intestinal mucosa (Figure 5).  
 Prebiotic and probiotic benefits incurred by the consumer include: competitive 
exclusion of pathogenic bacteria, increased absorption of nutrients, and well documented 
immunomodulating effects, such as the modification of the balance of immune cells in 
the intestinal mucosa (Vinderola, et. al., 2006; Maalouf, et. al., 2011; Medrano, 2011) 
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(see Figure 5).  Probiotic organisms can exert their beneficial properties through two 
mechanisms: direct effects of the live microbial cells (probiotics) or indirect effects via 
metabolites of these cells (biogenics) (Vinderola, et. al., 2004).  Biogenics are defined as 
food components that are derived from microbial activity which provide health benefits 
without involving the intestinal microflora (Takano, 2002).   
 
Figure 5.  Effects of probiotic bacteria and yeast on intestinal epithelial barrier function. 
(source: Ohand, et. al., 2010: https://s100.copyright.com/AppDispatchServlet#formTop)  
 
 Several strains of Lactobacillus delbrueckii and Streptococcus thermophilus 
produce EPS (Hong and Marshall, 2001).  In kefir, these loosely bound 
exopolysaccharides couls act as a stabilizer, preventing syneresis and graininess and 
provide a natural thickening effect (Cerning, 1990).  In regards to health, bacterial 
exopolysaccharides could provide benefits such as aiding in bacterial adhesion to the 
lining of the gut and protection of probiotics during transit though the gastrointestinal 
tract.   
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  Because the origins of lactic acid bacteria and yeasts are not human associated, 
they can be sensitive to the harsh conditions of the stomach and bile acids.  This aspect 
becomes president when considering the health benefits incurred by the consumer of 
probiotic containing products.   It has been shown that both the strain and the amount of 
probiotic species play a role in determining survival in the human gut (Elli, et. al., 2006 
and Conway, et. al., 1987); and the adhesion to intestinal epithelial cells may play a 
critical role in the immunostimulating and immunomodulating effects of certain probiotic 
species.  However, in vivo adhesion will most likely be influenced by both the normal 
microbiota and the specific probiotics included, but only few studies to date have directly 
examined the adhesion interactions of the probiotics and the intestinal mucosa 
(Ouwehand, et. al., 2000 and Collado, et. al., 2007).    
 In addition to the immunostimulating benefits of probiotics, kefir exhibits 
additional biological activities that include antibiotic and antifungal properties 
(Farnsworth, et. al., 2003); antioxidant action of probiotic bacteria towards numerous 
human pathogens has been also been observed in several studies  (Zacconi, et. al., 2003; 
Medrano, et. al., 2006; Ismaiel, et. al., 2011).  In a 2004 study, Rodrigues, et. al. 
demonstrated the antimicrobial and healing activity of kefir and kefiran extract; they 
showed that successful and faster wound healing occurred in rats when a topical kefiran 
mixture was used as alternative to antibiotics.  Other studies have demonstrated that 
antibacterial, antimycotic and antitumor activity of cells increase when exposed to kefir 





1.7 Physiological Effects of Endurance Exercise 
1.7.1 Metabolic Effects 
 Endurance exercise depletes the body’s glucose stores (blood glucose, muscle and 
liver glycogen) and can have a catabolic effect on muscle proteins immediately following 
exercise.  To most efficiently replenish energy stores and to maintain the functioning of 
skeletal muscles, adenosine triphosphate (ATP) is produced via the oxidative 
phosphorylation of carbohydrates, proteins and fats, as seen in Figure 6. During moderate 
physical activity intracellular glycogen and free fatty acids are the primary substrates 
utilized in the oxidative pathway; however, for endurance athletes, circulating glucose 
also provides a significant ATP source when exercising for prolonged periods of time 
(De Feo, et. al., 2003). 
 
Figure 6.  Rates of appearance of circulating glucose and free fatty acids (FFA) during 
exercise at graded intensities in humans.  VO2max: maximum oxygen uptake. (modified 
from: De Feo, et. al., 2003). 
  
 It has been well established that exercise can be a key strategy for improving 
health and is actually essential for good metabolic and cardiovascular function, of which 
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beneficial effects of high intensity exercise have been demonstrated in several controlled 
studies (Babraj, et. al. 2009; Little, et. al. 2011).  In order to optimize the metabolic, 
cardiovascular and psychological benefits that exercise can offer, Garber, et. al. (2011) 
advises people to perform a large volume (at least 30 min per day) of both moderate and 
vigorous intensity cardiorespiratory exercise on most days of the week, as well as 
strength and flexibility sessions 2–3 times per week.  However, Metcalf, et. al. (2012) 
demonstrated that shorter and more intense exercise sessions could infer beneficial 
effects as well by conducting a 6-week exercise intervention consisting of very brief, 
manageable sessions; results showed that a short exercise intervention was associated 
with improved insulin sensitivity in sedentary young men, and improved aerobic capacity 
in men and women.  When describing normal metabolic responses of individuals 
following exercise, differences between men and women must also be considered.  By 
following a traditional aerobic exercise intervention in a large cohort, Boule, et. al. 
(2005) demonstrated that insulin sensitivity improved to a greater degree in men when 
compared with women, but the female participants had a higher baseline level of insulin 
sensitivity which may, in turn, impact subsequent metabolic training responses.  
1.7.2 Immune Functioning 
 Prolonged intense exercise often results in perturbations in cellular aspects of 
immunity.  Strenuous and eccentric exercise seems to exert the most prominent changes 
in immune parameters with extreme exercise, such as marathons and other frequently 
used training programs, being associated with a depression in immune function 
(Fitzgerald, 1991).  In a 1992 study Keast, et. al. determined that regular, moderate 
training does seem to promote resistance to upper respiratory tract infection (URTI); 
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however, severe exertion, especially when coupled with mental stress, places athletes at 
increased risk for URTI (Nieman, 1994).  A limitation to these types of epidemiologic 
studies on exercise and URTI is that they are based on self-reported symptoms rather than 
clinical verification and can often be unreliable (Hoffman-Goetz, et. al., 1995). Figure 7 
shows the link between exercise associated immune changes and sensitivity to infection 
that may be explained by the so-called “open window” of altered immunity (Pederson 
and Toft, 2000). 
 
Figure 7.  Model of the proposed neuroendocrinological mechanisms underlying the 
exercise induced “open window” in the immune system. (modified from: Pedersen and 
Toft, 2000). 
 
 Many of the mechanisms underlying exercise associated immune changes are 
multifactorial and include important neuroendocrinological factors such as adrenaline 
(epinephrine), noradrenaline (norepinephrine), growth hormone, and cortisol 
(Newsholme, 1994).  The concentrations of these hormones typically increase during 
exercise and return to original values shortly after, but they also seem to exert effects on 
lymphocytes and neutrophils during the recovery period.  Pederson and Toft (2000) 
hypothesized that during the first few hours following exercise, when immune 
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suppression is most pronounced, viruses and bacteria may gain a foothold, increasing the 
risk of subclinical and clinical infection.   
1.7.3 Inflammation 
 Chronic inflammation is theorized to be the root cause for a number of associated 
diseases and disorders, such as chronic obstructive pulmonary disease, asthma, chronic 
heath failure, rheumatoid arthritis, diabetes mellitus type 1 and 2, inflammatory bowel 
disease (e.g., Crohn’s disease, ulcerative colitis), inflammatory myopathies (e.g., 
idiopathic, polymyositis, dermatomyositis, inclusion body myositis), juvenile idiopathic 
arthritis and multiple sclerosis (Abbas, et. al., 2007; Ploeger, et. al., 2009; Hotamisligil, 
et. al., 2006).  It has been theorized that the combination of an impaired immune response 
coupled with persistent immune stimulation may have a role in the low-grade systemic 
inflammation and altered cytokine balance, which may translate into increased 
cardiovascular diesase (CVD) risk (Stenvinkel, et. al., 2005; Adamopoulos, et. al, 2001).   
 Altered levels of cytokines are not only seen in inflammatory diseases; acute and 
chronic exercise can also have an effect on cytokine responses and inflammation in 
healthy individuals (Ploeger, et. al., 2009).  Superficially, the body reacts to physical 
activity as it does during an acute, subclinical inflammatory response to a perceived 
pathological insult (Ostrowski, et. al., 1998), and pro- and anti-inflammatory cytokines 
are released into the circulation (Northoff, 1994).  
 The effects of regular or chronic exercise on basal levels of inflammatory markers 
have been used to recommend exercise as an anti-inflammatory therapy (Adamopoulos, 
2002).  However, compared to acute bouts of exercise, the effects of chronic exercise on 
inflammatory markers have been less investigated. Whereas exercise of moderate 
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intensity is associated with anti-inflammatory effects (Bruunsgaard, et. al., 2005), 
strenuous exercise can affect resting levels of inflammatory markers during and after a 
period of intensive training (Gleeson, et. al., 2006; Gokhale, et. al., 2007).  In spite of the 
different backgrounds and symptoms related to the various diseases, all systemic chronic 
inflammation shares common characteristics, including elevated circulating levels of 
cytokines tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) under basal or 
resting conditions (Hotamisligil, 2006). 
1.8 Biological Measures of Inflammation and Immune Functioning 
 The immune system’s first lines of defense against microbial invasion are the 
external secretions that bathe mucosal surfaces (respiratory, intestinal and reproductive); 
secretory immunoglobulin A (sIgA) is a key component and is the dominant 
immunoglobulin present in mucosal secretions (King, et. al., 2003).  IgA is secreted by 
mucosal plasma cells that are adjacent to the salivary glands; once secreted from the cell 
the dimeric IgA it is bound and transported by a polymeric immunoglobulin receptor 
through the salivary cells (King, et. al., 2003).  The IgA dimer forms a complex with a 
fragment of the polymetric immunoglobulin receptor polypeptide and is released into the 
saliva as secretory IgA.  Studies have shown that sIgA levels vary in response to stress, 
mood and emotional state (Cohen, et. al., 2003). 
 TNF-α, also known as cachectin, is a non-glycosylated polypeptide cytokine that 
is produced primarily by activated macrophages with a large percentage of TNF-α 
production being the result of stimulation of macrophages by lipopolysaccharide 
(Beutler, et. al., 1895).  Therefore, TNF-α becomes an important mediator of the in vivo 
effects of lipopolysaccharide, and the inhibition of lipoprotein lipase and apidocyte gene 
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expression, in regards to metabolic activities, is strongly influenced by TNF-α (Dinerello, 
et. al., 2003). TNF-α is involved in various biological activities such as 
immunomodulating and proinflammatory activities by regulation of the production of 
antibodies by B cells and stimulation of cytotoxic T cells (Moldoveanu, et. al., 2000).   
Since TNF-α has also been shown to increase ubiquitin gene expression in skeletal 
muscle, it is possible that it causes muscle wasting by stimulating protein catabolism via 
the ubiquitin proteasome pathway (Stenvinkel, et. al. 2005).  In a 2000 review, Shek and 
Shepard stated that strenuous exercise-induced elevations in interleukin-1β and TNF-α 
have been reported, but results from different studies appeared inconsistent, possibly due, 
in part, to differences in experimental design, timing of blood sampling, and cytokine 
assay sensitivity (Thomson, 1998; Adampopoulos, et. al., 2001; Himmerich, et. al., 
2006). 
 C-reactive Protein (CRP) is formed primarily in hepatocytes with its rate of 
synthesis being primarily influenced by the cytokines involved in inflammatory 
processes, and because its half-life is estimated to be rather short (13-16 hours), serum 
CRP concentration can reflect acute infection, pneumonia and myocardial infarction 
(Cohen and Cohen, 2006). Several recent studies have demonstrated an association 
between inflammatory reactions and CVD such as both latent and chronic infections and 
arteriosclerosis. In fact, the CRP values found in Table 4 are often used by clinicians to 
assess systemic inflammation and are most notably used as a risk factor for CVD (Zulet, 
et. al., 2006).  However, because no accepted normal ranges for adult populations have 




Table 4. CRP concentration in plasma and correlated risk of coronary heart disease. 
C-Reactive Protein-
Concentration for Plasma 
Coronary Heart Disease-
Risk Level 
< 1 mg/l 
1-3 mg/l 




      (modified from: Pearson, et. al., 2003 
 
1.9 Sport Nutrition 
 According to the American College of Sports Medicine (ACSM) (2009), athletes 
should consume enough energy during periods of high-intensity and/or long-duration 
training in order to maintain body weight and health and to maximize training efforts. 
ACSM (2009) reports that low energy intakes can result in loss of muscle mass, 
menstrual dysfunction, loss of or failure to gain bone density, an increased risk of fatigue, 
injury and illness, and a prolonged recovery process.  Recommendations include a 
carbohydrate intake of approximately 1.0-1.5 g per kg body weight during the first 30 
minutes after exercise and again every 2 h for 4-6 h in order to adequately replace 
glycogen stores (ACSM, 2009) (Table 5). 
Table 5.  Macronutrient recommendations for athletes following exercise. 







              (adapted from: ACSM, 2009) 
 During exercise, carbohydrates maintain blood glucose levels and replace muscle 
glycogen. The ACSM carbohydrate recommendations for athletes range from 6 g/kg to 
10 g/kg body weight (Table 5). The amount required depends on the athlete's total energy 
expenditure, type of training, sex, and other environmental conditions, such as extreme 
heat or cold.  In an article examining the upper and lower limits of carbohydrate 
requirements for different types of athletic training, Jeukendrup (2013) concluded that 
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carbohydrate needs can reach much higher values (up to 90 g/h) for elite athletes 
exercising at higher absolute intensities or during an event lasting more than 2 hours. 
 Protein intake sufficient to maintain and increase muscle mass is necessary for 
optimal health and performance. Protein recommendations for endurance and strength-
trained athletes range from 1.2-1.7 g/kg body weight (0.5-0.8 g/lb body weight).  
Consumption of protein provides essential amino acids required for the synthesis of body 
proteins.  Amino acids also play key roles in the metabolic processes of many organs and 
tissues by serving as precursors and regulators in the production of metabolic mediators 
and compounds with regulatory biological activity e.g. hormones, neurotransmitters, 
DNA and RNA (Jeukendrup and Gleeson, 2010). 
 Fat is also important in the diet of athletes, not only as a source of energy, but 
because it provides fat-soluble vitamins and essential fatty acids.  The ACSM (2009) 
recommends a fat intake ranging from 20-35% of the total energy intake and goes on to 
state that consuming less than 20% of energy from fat does not benefit performance.  
 Adequate fluid intake before, during, and after exercise is critical for health and 
optimal performance to avoid dehydration, with a goal of drinking enough fluid to avoid 
dehydration but not in excess of the sweating rate. For fluid intake following exercise the 
ACSM recommends 16-24 oz (450-675 mL) of fluid for every pound (0.5 kg) of body 
weight lost during exercise. 
 Before exercise, a meal or snack should provide sufficient fluid to maintain 
hydration and ease of digestion and be relatively low in fat and fiber in order to facilitate 
gastric emptying and to minimize gastrointestinal distress. The food consumed should be  
relatively high in carbohydrates to maximize maintenance of blood glucose, moderate in 
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protein, be composed of familiar foods, and be well tolerated by the athlete (ACSM, 
2009).  The recommendation of the ACSM for nutrition during exercise is for athletes to 
replace fluid losses and provide carbohydrates at a rate of approximately 30-60 g/hour 
(ACSM, 2009). Following exercise, ingestion of enough fluids, electrolytes and 
carbohydrates to replace muscle glycogen will ensure rapid recovery, and protein 
consumed after exercise will provide essential amino acids needed for repair and building 
of muscle tissue (Maguhan, 1997).  Numerous studies have shown a 4 to 1 ratio of 
carbohydrates to protein to be the most beneficial macronutrient profile of a recovery 
food for athletes (Karp, et. al., 2008; Roy, et. al., 2008; Thomas, et. al., 2009).  The 
effects of certain foods on intestinal health and overall well being of athletes in reducing 
and preventing elevated inflammatory response and instances of suboptimal immune 
functioning, as seen by measuring specific markers such as CRP, are also very important 
variables to consider for proper sports nutrition. 
1.10 Probiotics and Exercise  
 Elevating and maintaining high levels of stress on the body, as often occurs with 
exercise, can cause acute and chronic disruption of immune functioning (Gleeson, et. al., 
2006).  In a review examining the relationship between probiotics and exercise, West, et. 
al. (2009) concluded that probiotic supplements modulate the intestinal microbial flora 
and offer promise as a practical means of enhancing gut and immune function in athletes.  
 Studies involving probiotics and athletes have demonstrated maintenance of 
gastrointestinal (GI) function and health by reducing the frequency and severity of GI 
issues including cramps, nausea, bloating and diarrhea during and following exercise 
(Berg, et. al., 1999).  Attenuation of immunosuppressive effects of exercise have also 
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been demonstrated in athletes receiving an encapsulated probiotic supplement during 
training (Bishop, et. al., 2009).  A similar study conducted by Kekkonen, et. al.  (2007) 
showed a reduced susceptibility to illness especially in regards to an enhanced resistance 
to upper URTI in athletes consuming probiotics.    
 Zonulin is a novel protein that modulates intestinal permeability by disassembling 
the intercellular tight junctions (TJs) (Wang, et. al., 2001). This protein is most likely 
involved in the innate immunity of the gut and, when upregulated, appears to play a key 
role in the pathogenesis of autoimmune diseases, such as celiac disease (Sapone, et. al., 
2006). Reduced gut permeability in athletes receiving a probiotic supplement during the 
course of a 14-week intensive cycling training course was demonstrated by a significantly 
lowered amount of zonulin in the feces of the probiotic group as compared to the placebo 
indicating reduced gut permeability in the probiotic supplemented group (Lamprechet, et. 
al., 2012).  In addition, Lamprechet, et. al. (2012) concluded that probiotic 
supplementation beneficially affected TNF-α and exercise induced protein oxidation. 
Many probiotic strains are also able to stimulate the production of IgA by B cells, which 
help maintain intestinal humoral immunity by binding to antigens, thereby limiting their 
access to the epithelium (Delcenserie, et. al., 2009).  
1.11 The Role of Dairy Foods in Sport Nutrition  
 Milk, supplemented with the recommended amount of carbohydrate, has been 
shown to be an ideal recovery beverage for athletes following bouts of resistance and 
endurance training as a way to attenuate some of the acute affects of strenuous activity 
(Roy, et. al., 2008; Thomas, et. al., 2009).  In a 2007 study, Wilkenson found that milk-
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based proteins promote muscle protein accretion to a greater extent than do soy-based 
proteins when consumed after resistance exercise. 
 The U.S. Department of Agriculture and U.S. Department of Health and Human 
Services 2010 Dietary Guidelines for Americans recommends milk as a healthful, protein 
and nutrient rich food source for people of all ages and activity levels. Milk is also a good 
source of calcium, phosphorous, vitamin D, riboflavin, and potassium (NIH, 2013).  
These nutrients play key roles in the development of strong bones and in restoring proper 
electrolyte balance and rehydration following exercise.  
 Although can milk play an important role in sport nutrition, athletes with lactose 
sensitivities are unable to consume lactose containing dairy products, such as 
unfermented milk, without some degree of gastrointestinal discomfort.  The production of 
lactase by mucosal cells in the intestinal epithelium decreases with age in most humans, 
particularly in individuals of East Asian and African descent (Suchy, et. al., 2010), and it 
is estimated that 65% to 85% of adults of these races lack sufficient lactase to digest the 
lactose that would accompany the Dietary Guidelines for American’s recommended 3 
servings per day of low-fat dairy products (Heaney, 2013).  According to a cross 
sectional diagnostic study performed by Srinivasan, et. al. (1998), the highest rates of 
lactose malabsorption were found in Asian populations, Native Americans and African 
Americans (60–100%) and lowest rates in people of northern European origin and the US 
white population (2–22%).   
 It is the absence of adequate hydrolysis of lactose in the small intestine (where the 
enzyme is normally active) that results in the passage of undigested lactose into the distal 
bowel where bacteria ferment the sugar, sometimes producing gas and symptoms such as 
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cramps, bloating, flatulence, and diarrhea (Tomba, et. al., 2012).  When lactose 
malabsorption gives rise to symptoms, this is called ‘lactose intolerance’.  However, 
because a large portion of the lactose (≥30%) in milk is metabolized by lactic acid 
bacteria in the kefir culture, symptom free consumption of the kefir beverage by 
individuals with lactose sensitivities is possible, allowing milk to be a healthful addition 
to the diet.   
 In addition to the many beneficial nutrients intrinsic to the milk itself, healthful 
properties acquired by kefir during fermentation could be of importance to athletes, such 
as an increased bioavailability of the protein in milk (Magalhaes, et. al., 2011) and an 
enhanced micronutrient profile (Farnworth, 2003).  In addition, several studies have 
shown the large amounts of medium and short chain fatty acids found in fermented milk 
are to aid in digestion and utilization of lipids (Kalser, 1971; Babayan, et. al., 1981; Fathi, 
et. al., 2015).  
 The capacity for probiotics to modulate perturbations in immune function after 
exercise highlight their potential for use in individuals exposed to high degrees of 
physical stress (West, et. al., 2009).  The increased biomass of the microbes and the 
production of cellular proteins, peptides and free amino acids, that are subsequently 
released into the kefir beverage, further enhance the digestibility of milk and would make 
a kefir recovery beverage a good source of nutrients required for muscle synthesis and 






1.12 Objectives  
The objectives of this project were to: 
1. Design an all natural, minimally processed post-exercise kefir based recovery 
beverage for athletes that meets 3 specific criteria: (1) follows the ACSM guidelines 
for endurance athlete nutrition following exercise, (2) has a significantly reduced 
lactose content to allow for consumption by lactose sensitive athletes, (3) contains 
live, active probiotic cultures at the time of consumption.   
2.  Determine the physiological responses to intensive exercise training and kefir 
supplementation by examining levels of established biological markers of 
inflammation and immune functioning 
3. Provide sensory and product survey components implementing both affective and 
descriptive methodologies to (1) provide insight into the role of nutrition in exercise  
and current dietary practices in college students and student athletes, especially as 
they relate to dairy foods, (2) assess the current recovery protocols being 
implemented by the participants, (3) quantify participant consumption of fermented 
dairy products, (4) collect sensory data that can be used to further refine the 









CHAPTER 2.  MATERIALS AND METHODS 
2.1 Experimental Design 
 A kefir beverage and a control beverage were administered in isocaloric amounts 
to 4 treatment groups: exercise training group supplemented with a non-fermented 
control beverage (n=11), exercise training group supplemented with a probiotic kefir 
beverage (n=14), active control supplemented with a non-fermented control beverage 
(n=21) and active control supplemented with a probiotic kefir beverage (n=21) (Table 6).  
Table 6.  Treatment group and sample size for subjects participating in a 15-week 
marathon training program and receiving a supplemental recovery beverage. 
Subject Group  Treatment 1:  
Exercise 




Exercise Training Control (ETC) 
Exercise Training Kefir (ETK) 
Active Control Control (ACC) 














 Throughout the intervention period, all subjects in all four groups completed 
weekly sickness, burnout, training/injury logs, diet records and sensory questionnaires 
relating to the beverages. Baseline measurements including height, weight, skinfold 
measurements and physical activity assessments were taken for all study participants.  
Subjects also were required to complete a 1.5-mile walk/run in the fastest possible time 
(Figure 8).  Venus whole blood and plasma/serum samples (10 mL per sample) (20 mL 
total) were collected at the beginning (Pre) and at the end (Post) of the intervention 
period and were analyzed for levels of CRP, TNF-α and sIgA. This project was approved 






Pre-intervention tests                                                                         Post-intervention tests 
Baseline resting measurements                                   Baseline resting measurements 
Blood collection                                                                                  Blood collection 
Diet log                                                                                                            Diet log 
1.5-mile walk/run                                                                                1.5-mile walk/run 
   
Exercise Training + Kefir Beverage (ETK) 
Exercise Training + Control Beverage  (ETK)        
 
 
I----------------------------------------15 week intervention ----------------------------------------I                                                          
 
 
Active Control + Kefir Beverage (ACK) 
Active Control + Control Beverage (ACC) 
 
Figure 8.  Experimental design 
  
2.2 Product Development 
 A kefir beverage and a control beverage were developed to meet the ACSM 
guidelines for recommended nutrition following endurance and resistance exercise.  All 
products were manufactured, packaged and stored at the Louisiana State University 
Creamery (123 Dairy Science Building, Louisiana State University, Baton Rouge).  
2.2.1 Fermented Milk Beverage  
 Pasteurized, non-homogenized, full fat cow’s milk was fermented in either gallon 
sized lidded glass containers or 5 gallon lidded stainless steel milk pails by inoculation 
with approximately 30 grams of kefir grains (Cultures for Health, Sioux Falls, SD) per 
gallon of milk.  During the fermentation process, the kefir grains were contained in 
unbleached cotton tea bags (Figure 9).  The bags were sterilized in boiling water before 
addition of the kefir grains.  The milk was allowed to ferment at 25°C for approximately 
24 hours, or until a pH of 4.6 was reached.  The kefir was then placed in refrigerated 
storage until formulation and packaging of the beverage.  
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 The fruit base for the kefir beverage was processed separately and was 
subsequently blended with kefir several hours prior to consumption by the study 
participants. The fruit base included all ingredients, except the dairy portion; it was 
prepared using a VitaMix Commercial/Household Food Preparing Machine Model 
VM0100A.  After combining the kefir and the fruit base, sixteen ounces of the product 
were portioned into clear plastic containers with snap on lids with a tamper evident seal.  
Each container was labeled with a number that corresponded to a coded system indicating 
the intended date of consumption and manufacture date. The containers were placed in 
refrigerated storage (6±5°C) until consumption.  No other identifying information was on 
the container when presented to the participants.   
2.2.2 Control Beverage 
 The non-fermented milk beverage was made using a VitaMix Commercial and 
Household Food Preparing Machine Model VM0100A.  Lactaid®, an ultra-pasteurized 
homogenized lactose-free milk product, was used as the dairy portion of the control 
beverage. 
 The fruit base for the control beverage was processed separately and was blended 
with Lactaid®  several hours prior to consumption by the study participants. The fruit base 
included all ingredients except the dairy portion; it was prepared using a VitaMix 
Commercial/Household Food Preparing Machine Model VM0100A. After combining the 
Lactaid® and its fruit base, sixteen ounces of the product were portioned into clear plastic 
containers with snap on lids with a tamper evident seal. The filled containers were placed 
in refrigerated storage (6±5°F) until consumption.  Each container was labeled with a 
number that corresponded to a coded system indicating intended date of consumption and 
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manufacture date.  No other identifying information was on the container when given to 
the subjects for consumption.    
2.2.3 Quality Control Testing  
 To ensure the microbiological safety of the product 1 ml of each batch of the 
finished kefir was plated on E. coli/coliform Petrifilm™ (3M, St. Paul, WI); each batch 
of the fruit base was also tested.  Finally, each batch of the final kefir beverage and the 
final control beverage was tested by plating 1 ml of the prepared products on E. 
coli/coliform Petrifilm™.  The petrifilm was incubated aerobically at 32°C for 
approximately 24 hours.  All beverages consumed by the participants had a coliform 
count of <1 cfu/ml.  The percent titratable acidity (0.80±0.04 %) and pH (4.43±0.06) of 
each batch of kefir used in the kefir beverage was also assessed to ensure consistency of 
the finished product.  Lactose levels in the kefir were determined using the 
Enzymatic/UV method (r-biopharm AG, Darmstadt, Germany).  Percent lactose in the 
kefir was 3.49-3.56 % w/w, indicating a 30% reduction of lactose during fermentation. 
Quality control testing was conducted in the Dairy Science Laboratory (119 Dairy 
Science Building, Louisiana State University, Baton Rouge). 
2.2.4 Nutritional Analysis 
 The nutrient profiles of the kefir beverage and the control beverage were identical 
and described in Table 7.   
Table 7. Nutrient profile of recovery beverage given to endurance athletes participating in 

















16  220.16 5.4 71.68 66.56 2.8 30.72 10.24 
12 165.12 4 53.76 50 2 23.04 7.7 
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 Nutritional analysis for the products and ingredients was performed using The 
Food Processor® Nutrition and Fitness Software (ESHA Research, Professional 
Nutritional and Analysis Software, Salem, OR).  Macronutrient contents for each 
ingredient were generated by The Food Processor® software and the total macronutrient 
composition for each beverage was calculated from those values (Table 8 and Table 9).  
Table 8.  Composition of a kefir beverage given to endurance athletes and an active 
control during a 15-week marathon training program. Weights, nutrients and probiotics 
are reported as mean values. 
 
 
Table 9.  Composition of a control beverage given to endurance athletes and an active  
control during a 15-week marathon training program. Weights, nutrients and probiotics 
are reported as mean values. 
 
2.3 Subject Recruitment         
 The marathon training group was recruited from a Louisiana State University 
class, Kinesiology 4526: The Physiology of Endurance Training.  The instructor of this 
course was Laura Stewart, Ph.D. In addition to traditional coursework, the students 
Weight Calories Fat Sodium Total33Carbs Fiber Sugar Protein
Kefir 672 448.5 25 338.5 34.5 0 34.5 26
Honey 72 219 0 3 225 1.8 60 0
Strawberries 128 46 0 1 10 3 6 1
Banana 354 315 1 3.5 56 9 43 3.5
Vanilla3extract 13 37 0 1 1.5 0 1.5 0
Stevia >1 0 0 0 0 0 0 0
Batch3total 1239 1065.5 26 347 327 13.8 145 30.5
Per3gram 1 0.86 0.021 0.28 0.26 0.011 0.12 0.04
Serving3(123oz) 192 165.12 4 53.76 50 2 23.04 7.7
Serving3(163oz) 256 220.16 5.4 71.68 66.56 2.8 30.72 10.24




 cfu/g       







enrolled in this class were training for a marathon and completing the below 
measurements as part of the course requirements.  Students interested in joining the 
training group portion of this study were asked after the KIN 4526 class period if they 
would allow us to use data collected in the class for research purposes.  Students were not 
penalized for not participating in the study.  While there was 100 percent participation by 
the students in this course, any students who chose not to participate in this research 
study were offered an alternate assignment for course credit. The participants in this class 
were assigned randomly into two beverage treatment groups (ETC and ETK).          
 The subjects for the active control groups were recruited from a Louisiana State 
University sanctioned class, Kinesiology 3515: The Physiological Basis of Activity, also 
taught by Laura Stewart, Ph.D. The subjects in the active control group were randomly 
assigned to their beverage groups (ACC and ACK).    
 All subjects passed a required health screening and were between the ages of 18-
35 years.  General exclusion criteria for all subjects were as follows:  the presence of 
disease conditions including diabetes, cardiovascular disease, cancer, human 
immunodeficiency virus, asthma, resting blood pressure >160/100 mm Hg, 
hospitalization within the last 6 months, plans to be away for more than 2 weeks in the 
next 9 months, significant weight loss in the past year (> 20 kg) or current use of weight 
loss medications, being pregnant or planning to become pregnant within the next 6 
months.    
2.4 Medical and Health History Screening 
 Subjects in the ETC and ETK first received permission to participate from a State 
licensed M.D. or D.O. (Appendix B).  Medical clearance was not required for the ACC 
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and ACK because they were instructed to follow their normal workout routine without 
our supervision.  All study participants completed a medical history form, Physical 
Activity Readiness Questionnaire (PAR-Q) and International Physical Activity 
Questionnaire (IPAQ) (Appendix B). The above screening and questionnaire were 
designed specifically with the participant’s health in mind by:  1) preventing those with 
pre-existing conditions from participating in a running program/study and 2) allowing the 
researchers to become aware of any potential health issues.  Subjects were also informed 
of the ingredients found in the product to eliminate any risk of health issues due to 
allergens and other food sensitivities.  A signed waiver, indicating that food ingredients 
and information concerning possible allergens were disclosed, was required from all 
participants prior to inclusion in the study (Appendix B). 
2.5 Pre-Intervention Data Collection: Baseline Resting Measurements 
 Baseline measurements (body composition, blood/saliva collection, 
questionnaires) were taken at the Nutrition and Human Assessment Laboratory, 252 
Knapp Hall, Louisiana State University, Baton Rouge, LA.  Subjects were instructed to 
refrain from exercising on the day of testing and to wear lightweight, comfortable 
clothing (including a sports bra and shorts underneath) that did not contain any metal. 
Upon arrival, the subjects were given the Participant Consent Form (Appendix C) and 
given time to review the document.  Then, the experimental protocol was explained, and 
any questions posed by the subjects were answered.  
2.5.1 Body Circumference/Body Composition 
 Skinfold measurements were taken in triplicate from three sites by a kinesiology 
graduate student, Laura Forney.  For men the three sites measured were chest, abdomen 
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and thigh; for women the three sites measured were triceps, suprailiac and thigh. 
Measurements were taken by pinching the skin and then measuring with a spring-loaded 
Lange skinfold caliper (Cambridge Scientific Industries, Inc., Cambridge, MA) allowing 
the caliper to pinch the skin. Subjects were made aware of slight discomfort and possibly 
bruising on rare occasions experienced from the pinching and measuring of skinfolds. 
Hip and waist circumference was measured using a Gullick anthropometric tension tape 
(Patterson Medical, Cedarburg, WI). Subjects were then weighed barefoot on a digital 
platform scale and height was measured using a stadiometer.   
2.5.2 Saliva Collection 
 Saliva was collected from all study participants. The subjects were asked to fast 
for at least four hours before the scheduled donation time. Briefly, subjects were 
instructed to passively drool by tilting their head forward, allowing saliva to pool on the 
floor of the mouth, and, without force, the pass the saliva into a sterile tube for 10 
minutes or until four 1 ml polypropylene vials were filled. All samples were labeled with 
subject codes and elapsed time to completion was recorded for each participant.  The 
filled sample vials were kept in wet ice during the collection period and then frozen in a 
laboratory chest freezer at -80°C until analysis. 
2.5.3 Blood Collection 
 Venus whole blood (10 mL per sample) and plasma/serum samples (10 mL per 
sample) (20 mL total) were collected before (PRE) and following (POST) the 
intervention period from consenting study participants; the blood sample collection was 
not a mandatory measurement.  Consenting participants were compensated $25 for each 
blood sample collection.  Subjects arrived to the Nutrition and Human Assessment 
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Laboratory (252 Knapp Hall, Louisiana State University, Baton Rouge, LA) between 
6:00 and 9:00 AM following an overnight fast and having refrained from exercise for the 
previous 72 hours. The subjects were seated quietly for 15 minutes before the blood 
samples were collected by a Registered Nurse, Nicole Petty.  Aliquots designated for 
plasma were collected in a Vacutainor™ blood collection tube containing 
ethylenediaminetetraacetic acid (EDTA) (BD, Franklin Lakes, NJ), a strong 
anticoagulant, and the tubes were centrifuged (within 5 minutes following collection) for 
15 minutes at 1000 x g and 4°C in order to separate the plasma from the cells. The 
plasma was transferred to microcentrifuge tubes, labeled with subject codes and stored in 
a laboratory chest freezer at  -80°C until analysis.  Aliquots to be used for analysis of 
serum components was collected in a Vacutainor™ blood collection tube containing a clot 
activator.  The blood was allowed to clot by sitting at room temperature for 
approximately 60 minutes before it was centrifuged for 15 minutes at 1000 x g and 4°C.  
2.5.4 Timed 1.5 Mile Run/Walk 
 The timed 1.5-mile walk/run served as the baseline exercise measurement for all 
subject groups.  Subjects were instructed to cover 1.5 miles in the fastest possible time 
(walking was allowed, but the objective was to finish in the shortest amount of time).  
The elapsed time was called out and recorded (in minutes) as the subjects crossed the 
finish line.  
2.6 Exercise Training 
 The marathon training program consisted of two supervised training sessions 
(running, swimming, strength training/drills) and one unsupervised training session each 
week during the 15-week training period (Appendix A). The unsupervised training 
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sessions were self-reported; however, the athletes were encouraged to participate in a 
student-led running group.  
2.7 Kefir Supplementation 
 Kefir and control beverages were administered in isocaloric amounts to the ETK 
and ETC groups within 30 minutes after completion of a Tuesday and Thursday run at 
approximately 4:00 PM (Appendix A). Subjects in the ACK and ACC groups consumed 
the beverages during Tuesday/Thursday class periods scheduled from 1:40 to 3:00 PM.  
Beverage consumption was supervised, and all empty beverage bottles were returned to 
ensure the beverages were being consumed in full and also to identify any absent study 
participants (Figure 17).  Participants who were absent during a scheduled class period or 
training session were given 24 hours to complete the training session (ETC and ETK) and 
to consume the beverage. 
2.8 Sickness and Injury Questionnaires 
 Throughout the 15-week training period, subjects in both training and active 
control groups completed weekly reports that included a sickness questionnaire 
(instances, duration and severity of illness) and a training and injury recall log (type, 
severity, duration) (appendix E).  The questionnaires were distributed to the participants 
at the beginning of each Tuesday class period and returned to the investigators the 
following Tuesday. Detailed instruction regarding proper completion of the 
questionnaires was provided at the beginning of the study. 
2.9 Athlete Burnout Questionnaire 
 To assess the emotional response to training by athletes throughout the 15 week 
training program, the Athlete Burnout Questionnaire (ABQ) (Raedeke and Smith, 2001) 
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was used (Appendix E).  The ABQ contains 15 items that assess three subscales of sport 
burnout: a reduced sense of accomplishment, emotional and physical exhaustion, and 
sport devaluation.  Participants responded using an ordinal scale ranging from 1 to 5, with 
1 denoting “almost never” and 5 denoting “almost always.”  The 1st and 14th items were 
reversed scored.  The questionnaires were distributed to the participants at the beginning 
of each Tuesday class period and returned to the investigators the following Tuesday. 
Detailed instruction regarding proper completion of the ABQ was provided at the 
beginning of the study. 
2.10 Sensory Surveys 
 Subjects were also asked to complete brief sensory questionnaires relating to the 
beverage and its sensory attributes (appendix F).  Before beginning the intervention the 
study participants were given a survey containing questions relating to prior knowledge 
of sport nutrition and types of foods and beverages, if any, being consumed following 
exercise.  The preliminary sport nutrition survey also contained questions regarding 
consumption of kefir and other fermented dairy products.  The participants completed a 
product evaluation survey on the first day that they received their beverage as well as two 
additional times during weeks 4 and 10 of the intervention period.  For this survey the 
participants were asked to evaluate the product and mark their response on a 9-point 
hedonic scale with 1=Dislike Extremely and 9=Like Extremely.  Sensory attributes 
included on the product evaluation form included aspects of appearance, aroma, taste and 
overall liking.  The third sensory evaluation was in the form of an exit survey; questions 
in this survey related directly to the participants willingness to buy this product, 
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perceived effects of this product on exercise recovery and overall experience of 
consuming the product.      
2.11 Post-Intervention Data Collection 
 One week prior to the marathon event, participants in the training and the active 
control groups underwent post-training measures. Procedures for post-training 
measurements were identical to the protocol followed for the baseline resting and 
exercise measures as outlined in the Pre-intervention measurements (see Chapter 2.5).  
2.12 Sample Analysis: Enzyme-Linked Immuno-Sorbent Assay (ELISA)  
 Wells of a microtiter plate were coated with polyclonal antibodies that were 
directed against the samples and standards.  Samples and standards containing the target 
compound were added to the microtiter plate and the target compound in the samples was 
bound, in excess, to the coated polyclonal antibodies (the capture antibody) in the first 
incubation step; washing removed any unbound substances.  Prior to a second incubation, 
an antibody specific to the target compound was added, binding to the target compound 
that was immobilized in the first incubation; another washing removed all unbound 
substances.  The solid phase was then incubated with an enzyme and a substrate.  The 
enzyme bonded to the target compound/antibody complex and acted upon the added 
substrate to produce a color of varying intensity that was, depending on the particular 
assay, either directly or inversely proportional to the amount of target compound present 
in the sample. Serum CRP was measured using an ELISA (Alpco Diagnostics, Salem, 
NH). TNF-α was measured using a TNF-α enzyme linked immune-sorbant assay 
(ELISA) (Alpco, Salem, NH).  Salivary IgA was measured using a Salivary Secretory 
IgA Enzyme Immunoassay Kit (Salimetrics, State College, PA). 
47 
 
2.12.1 CRP ELISA 
 A wash buffer was made by diluting 50 ml of the wash buffer concentrate with 
450 ml of deionized water, yielding a 1:10 solution.  Crystals occurring in the wash 
buffer concentrate, due to high concentrations in stock solutions, were dissolved at 37°C 
in a warm water bath prior to dilution.  The wash buffer remaining following completion 
of the assay was kept in refrigerated storage for use in subsequent CRP assays.  The 
conjugate was diluted to a 1:100 solution by adding 100 microliters (µl) of the conjugate 
concentrate into 9900 µl of the previously diluted wash buffer. Plasma samples were 
diluted to 1:100 by adding 10 µl plasma to 990 µl of the sample buffer.  A dilution factor 
of 100 was used to calculate the CRP concentration read off of the calibration curve 
generated for each assay. 
 Prior to use in the assay all reagents and samples were allowed to come to room 
temperature (18-26°C) and were mixed thoroughly.  To begin, the microtiter strips were 
washed 5 times by dispensing 250 µl of diluted wash buffer into each well.  After the 
final washing step the residual wash buffer was removed by tapping/blotting the plate on 
clean, absorbent paper towels. To duplicate wells, 100 µl of each sample standards and 
controls were added. The plate was covered tightly and incubated for 1 hour at room 
temperature on a horizontal mixer.   
 After the incubation period the contents of each well were discarded by quickly 
inverting the microtiter plate, and the wells were washed 5 times by dispensing 250 µl 
wash buffer into each well.  The residual wash buffer was removed by tapping the plate 
on absorbent paper towels.  Following washing 100 µl conjugate was added to each well. 
The plate was covered tightly and allowed to incubate for another hour at room 
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temperature on a horizontal plate mixer.  After the incubation period the contents of each 
well were discarded, and the wells were washed 5 times by dispensing 250 µl bash buffer 
into each well.  The residual wash buffer was removed by tapping the plate on absorbent 
paper towels.  Addition of 100 µl of substrate into each well was followed by a 10-20 
minute incubation at room temperature in the dark.  Because the intensity of the color 
change was temperature sensitive, the color change was observed and the reaction was 
stopped once good differentiation is achieved.  The reaction was stopped by addition of 
50 µl of stop solution, which was mixed thoroughly by gently tapping the side of the 
plate.   
 The absorption was determined immediately following completion of the assay 
with a microplate reader set to a detection wavelength of 450 nanometers (nm).  A 4-
parameter-algorithm was used to calculate the results.  A linear ordinate was used for 
optical density and a logarithmic abscissa was used for concentration with a zero 
calibrator specified for values less than 1 (e.g. 0.0001). The values obtained from the 
calibration curve were multiplied by 100 in order to calculate the CRP concentration in 
the plasma samples. 
2.12.2 TNF-α ELISA 
 The provided Human TNF-α (Hu TNF-α) standard was reconstituted to 2000 
picograms per milliliter (pg/mL) with standard diluent buffer. The solution was swirled 
gently to mix and allowed to sit for 10 minutes to ensure complete reconstitution.  After 
10 minutes 0.300 mL of the reconstituted standard to a tube containing 0.300 mL of the 
standard diluent buffer and was labeled 1000 pg/mL Hu TNF-α Mix.  Then 0.300 mL of 
the standard diluent buffer was added to each of six 1.5 mL sample tubes labeled 500, 
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250, 125, 62.5, 31.2 and 15.6 pg/mL Hu TNF-α.  These were the standards used to 
produce the standard curve.   
 The standards were made from the first dilution: 0.300 mL of the contents were 
transferred from the provided standard to a tube containing 0.300 mL of the standard 
diluent buffer and the respective serial dilutions were made.  A tube containing 0.300 mL 
of the standard diluent buffer only was used as the 0 pg/mL standard for the purposes of 
constructing the standard curve.  The streptavidin horse-radish peroxidase (streptavidin-
HRP) was prepared by adding 120 µL of the concentrate with 12 mL of streptavidin-HRP 
diluent.  The diluted solution was labeled streptavidin-HRP working solution.  The wash 
buffer concentrate (25X) was allowed to reach room temperature and was mixed well to 
ensure that any precipitated salts were re-dissolved.  One part of the wash buffer 
concentrate (25X) was mixed with 24 parts of deionized water. Working wash buffer was 
prepared by diluting by adding 50 mL of wash buffer concentrate with 1,200 mL 
deionized water. 
 All reagents were allowed to reach room temperature and the liquids gently mixed 
before use. First, 100 µL of the standard diluent was added to zero wells and 100 µL of 
the standards, samples and controls were added to the microtiter wells. Then, 50 mL of 
incubation buffer was added to the wells containing the standards and the serum samples. 
The plate was covered and incubated at room temperature for 2 hours. Following 
incubation, the solution was thoroughly decanted from the wells and discarded. The wells 
were then washed 4 times. The working wash buffer solution was put into a squirt bottle 
and the plate was flooded with wash buffer, completely filling all the wells.  The plate 
was inverted and tapped dry on clean paper towels after each wash. Each well, except the 
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chromogen blank, received 100 µL of biotinylated anti-TNF-α (biotin conjugate) solution 
and the plate was gently tapped on its side to mix. The plate was covered and incubated at 
room temperature for 1 hour.  Following incubation, the solution was again decanted and 
discarded and the plate was washed 4 times. Each well, except the chromogen blank, 
received 100 µL of streptavidin-HRP working solution. The plate was covered for 
incubation at room temperature for 30 minutes.  Following incubation, the plate was 
decanted and washed 4 times, and 100 µL of the stabilized chromogen was added.  Upon 
the addition of the stabilized chromogen the liquid in the wells began to turn blue.  The 
plate was then incubated in the dark for 30 minutes.  After the final incubation 100 µL of 
the stop solution was added to each well and the plate was tapped gently to mix.  The 
stop solution caused the solution in the wells to change from blue to yellow. 
 The absorbance of each well was read at 450 nm.  The plate reader was calibrated 
against a chromogen blank composed of 100 µL each of stabilized chromogen and stop 
solution. The plates were read immediately after adding the stop solution.    
2.12.3 SIgA ELISA 
 All reagents were allowed to come to room temperature (approximately 25°C) 
and were mixed thoroughly before use by inverting each bottle several times.  The 
microtiter plate was also allowed to come to room temperature at this time.  Precipitated 
matter in the concentrated wash buffer was re-dissolved by heating the concentrate bottle 
to 40°C for approximately 10 minutes; the concentrate was allowed to return to room 
temperature before use in the assay.  The wash buffer was prepared by adding 100 ml of 
the 10X concentrate into 900 ml of deionized water to create a 1:10 dilution.  
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 SIgA diluent was prepared by diluting the 50 ml of the sIgA diluent concentrate 
into 200 ml of deionized water to make a 1:5 dilution. The lyophilized stop solution was 
reconstituted with 10 ml of deionized water and was allowed to sit undisturbed for 10 
minutes before mixing well. 
 To prepare the sIgA standards 6 microcentrifuge tubes were labeled 1 to 6; 15 µl 
of the provided 600 µg/ml standard (tube 1) was added to tube 2 and 30 µl of the sIgA 
diluent was added into tubes 2 through 6.  The standards were serially diluted as follows: 
15 µl of the 600 µg/ml standard was added to tube 2 and the tube was briefly vortexed, 15 
µl of the solution from tube 2 was pipetted into tube 3.  This dilution was continued for 
tubes 4, 5 and 6 yielding final concentrations of 600 µg/ml, 200 µg/ml, 66.7 µg/ml, 22.1 
µg/ml, 7.4 µg/ml, and 2.5 µg/ml. 
 The samples were vortexed followed by centrifuging for 10 minutes at 3000 
revolutions per minute (rpm) for 15 minutes to remove any mucins that could interfere 
with antibody binding in the sample wells.  From the clear portion 25 µl of each sample 
was pipetted from the centrifuged samples into small microcentrifuge tubes labeled with 
the identity of each saliva sample and containing 100 µl of the prepared sIgA diluent to 
create a 1:5 dilution.  Each tube was lightly vortexed to mix.  Finally, 10 µl of the 
standards, controls, and 1:5 diluted unknowns were added to separate 12 x 75 mm capped 
tubes containing 4 ml of the sIgA diluent, and 10 µl of the sIgA diluent was added to a 
zero tube.  All tubes were vortexed to mix.   
 An initial incubation with the conjugate was performed in the tubes containing the 
standards, controls and unknown samples.  They were inverted several times to mix and 
were incubated at room temperature for 90 minutes.  Before transfer to the assay plate the 
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tubes were inverted again, and 50 µl from each standard, control and sample tube was 
added to the respective well on the microtiter plate.  An amount of 50 µl of the sIgA 
diluent was added to each well. The plate was covered and incubated at room temperature 
for 90 minutes with continuous shaking at 400 rpm.  Following incubation the plate was 
washed and decanted 6 times by adding 300 µl of the wash buffer into each well.  The 
plate was blotted on clean paper towels.  To each well 50 µl of the provided 3,3’,5,5’-
tetramethylbenzidine (TMB) solution was added with a multichannel pipette.  The plate 
was then mixed on a horizontal plate mixer for 5 minutes at 500 rpm and incubated for an 
additional 40 minutes at room temperature in the dark.  With a multichannel pipette, 50 µl 
of stop solution was added to each well. The plate was then mixed on the horizontal 
mixer for approximately 3 minutes at 500 rpm, until all the wells turned from green to 
yellow.   
 Immediately following completion of the assay the plate was placed in a 
microplate reader at 450 nm.  The average optical densities (OD) for each set of duplicate 
sample wells, the percent of SIgA bound (B/Bo) for each standard, control and sample 
was determined by dividing the average OD (B) by the average OD for the zero (Bo).  
The concentrations of the controls and unknowns were determined by interpolation by 
logistics using a 4-parameter non-linear regression curve fit (Gen5 Data Analysis 
Software, Winooski, VT).  The concentrations of unknown saliva samples were 
multiplied by 5 to obtain the final SIgA concentrations in µg/ml.  Samples that had values 
greater than 600 µg/ml were tested again, in subsequent assays, by preparing the samples 




2.13 Statistical Analysis   
 All statistical analysis was carried out in JMP Pro 11 (SAS Software, Cary, NC). 
A MANOVA was used to identify significant interactions (p<0.05).  Group means and 
standard deviations were calculated for all descriptive and outcome variables.  Student’s 
t-tests were performed post hoc for any significant differences detected at the α = 0.05 
level.  All CRP, TNF-α and sIgA samples were tested in duplicate. Concentrations of 
CRP were log transformed to adjust for normality for statistical analysis. Mean burnout 
scores and standard deviations were computed for each burnout subscale to determine the 
student-athletes’ burnout levels.  A series of one-way between-subject ANOVAs and 
independent t-tests were computed to identify and further examine any significant 
differences in burnout levels.  Data from sensory testing was also analyzed using JMP 
Pro 11 (SAS Software, Cary, NC).  For the sensory testing, ANOVA was done to analyze 
the questions with the 9-point hedonic scale (Peryam and Pilgrim, 1957). A frequency 
count was used to analyze the subject responses to Yes/No questions presented in the 











CHAPTER 3.  RESULTS AND DISCUSSION 
3.1 Endurance Training  
 The effect of exercise training and kefir supplementation on 1.5-mile times is 
shown in Figure 9.  There was a significant time x training group interaction (p = 0.0124) 
(Figure 21) with the ET groups (ETK and ETC) experiencing an average of 4.11% 
improvement in 1.5-mile time (Table 10).   
 
Figure 9.  1.5-mile time for subject groups before and after the 15-week intervention 
period. *Means for each bar differ significantly (P < 0.05). 1.5-mile times are reported as 
mean ± SD. Pre exercise training and post exercise training values were collected at the 
beginning and the conclusion of a 15-week marathon training program. ETC=Exercise 
Training + Control Beverage; ETK=Exercise Training + Kefir Beverage; ACC=Active 
Control + Control Beverage; ACK= Active Control + Kefir Beverage.  
 
 There was a significant (p<0.05) improvement in the 1.5-mile times with the ETK 
group having a Pre time of 12.24 minutes and Post time of 11.74 minutes, resulting in a 
30 second improvement for the group.  The ETC group had an average 1.5-mile time of 
11.98 minutes at the beginning of the 15-week protocol (Pre) and 11.79 at the end of the 
































significantly (p>0.05) improved 1.5-mile times (ETK), both the ACC and the ACK 
groups had significantly (p<0.05) slower times Pre-intervention as compared to Post-
intervention.  The ACC group had an average Pre time of 13.14 minutes and a post time 
of 14.02 minutes, which was a significant (p<0.05) increase in 1.5-mile time by 46 
seconds.  The ACK group had an average Pre time of 14.35 minutes and an average post 
time of 15.39 minutes resulting in a significant (p<0.05) increase in 1.5-mile time by 62 
seconds. 
Table 10.  Average percent change in 1.5-mile walk/run times for endurance training 
athletes and an active control consuming a kefir recovery beverage and a control 
beverage.  










abGroup means not connected by a common letter are significantly different (p < 0.05). 
*Significant improvement (p<0.05) in mean1.5-mile time. ETC=Exercise  Training + 
Control Beverage; ETK=Exercise Training + Kefir Beverage; ACC=Active Control + 
Control Beverage; ACK= Active Control + Kefir Beverage. 
  
 The improvement in mean 1.5-mile time in the ETK group demonstrated the 
effectiveness of the training program in achieving the desired results.  The endurance 
capacity i.e. aerobic capacity is most the often and most accurately measured by the 
maximum oxygen uptake (VO2max) during a graded exercise (treadmill) test.  However, 
testing the VO2max of individual subjects can be both costly and time consuming.   The 
1.5-mile walk/run test has been shown as a valid measure to estimate VO2 max and is 
commonly used in a college setting when it is necessary to test a large number of people 
at one time (Larsen, et. al., 2002). 
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 While accepted as a suitable VO2max predictor in lieu of a graded exercise test 
(Jeukendrup, et. al. 2010), there are several factors that may limit the accuracy of the 1.5-
mile walk/run test such as the undetermined accuracy and validity of the 1.5-mile 
protocol between male and female populations (Kline, et. al., 1987).  Also, although 
participants were instructed to “complete the course in as fast a time as possible” 
untrained individuals may not have been able to maintain a proper pace resulting in a 1.5-
mile time that does not represent the actual endurance capacity. 
3.2 Body Density and Percent Body Fat  
 The skinfold measurement equations estimated body density, which was then 
used to estimate percent fat.  The two generalized equations used to calculate body 
density were from Jackson and Pollock (1978) for men and Jackson, Pollock, and Ward 
(1980) for women (Table 11).  
Table 11.  Equations used for the calculation of body density and percent body fat based 
on skinfold data collected during resting baseline measurements. 
 Body Density Skinfold Measurements 
Females 
Males 
1.0994921 - 0.0009929*Σ + 0.0000023*Σ2 - 0.0001392*age 
1.1093800 - 0.0008267*Σ + 0.0000016*Σ2 - 0.0002574*age 
triceps, suprailiac, thigh  
chest, abdominal, thigh  
 Percent Body Fat✜ Σ = sum of skinfold        
measurements 
 [(4.570 / Body Density) - 4.142] * 100 ✜ percent body fat equation 
for males and females 
 
 Body density was calculated by the Body density of the participants before and 
after the 15-week training period is reported in Figure 10.  No significant differences 




Figure 10.  Body density of study participants before and after the 15-week intervention 
period.  There were no significant (p>0.05) differences in density body found between 
treatment groups or pre-intervention and post-intervention. Body density is reported as 
mean ± SD. Pre exercise training and post exercise training values were collected at the 
beginning and the conclusion of a 15-week marathon training program. ETC=Exercise 
Training + Control Beverage; ETK=Exercise Training + Kefir Beverage; ACC=Active 
Control + Control Beverage; ACK= Active Control + Kefir Beverage. 
 
 There were two calculation steps for determining percent fat: determining body 
density and then using body density to estimate percent fat.  The equation used for 
estimating percent fat from body density was the Brozek (2006) formula (see Table 11). 
Percent body fat of the participants before and after the 15-week training period is 
reported in Figure 11.  No significant differences (p>0.05) were found between or within 
groups in regards to variations in body fat percentage.  These results, indicating that the 
participants in this project had no significant fluctuations in weight during the course of 
the 15-week protocol, suggest that the kefir beverage and the control beverage did not 
differ in their effect on the body composition of participants over the course of the 
intervention.  The no change in mean body composition of participants in the ETC and 



























consistent body composition during training, with the supplementation with a dairy based 
recovery beverage possibly contributing to this consistency. 
Figure 11.  Percent body fat of study participants before and after the 15-week 
intervention period.  There were no significant (p>0.05) differences in percent body fat 
found between treatment groups or pre-intervention and post-intervention. Body fat 
percent is reported as mean ± SD.  Pre exercise training and post exercise training values 
were collected at the beginning and the conclusion of a 15-week marathon training 
program. ETC=Exercise Training + Control Beverage; ETK=Exercise Training + Kefir 
Beverage; ACC=Active Control + Control Beverage; ACK= Active Control + Kefir 
Beverage. 
 
 The equations used to determine body density have withstood the test of 
numerous cross-validation studies, with standard errors ranging from 3.6% to 3.8%, and 
are routinely used in body density assessment by sport and health professionals 
(Jeukendrup, et. al., 2010).  
 However, a limitation to this formula is that it assumes the density of fat-free 
mass to remain constant across the population when it in fact varies. The actual percent 
body fat tends to be somewhat higher than the measured percent fat in the lean, muscular 
individual and the opposite effect in obese individuals (Brožek, et. al., 2006).  Table 12 
























Table 12.  Descriptive categories for ranges of body fat percentage ranges in women and 
men issued by The American Council of Exercise. 
Description Women  Men 
  Essential fat 
  Athletes 
  Fitness 
  Average 











    (adapted from: American Council on Exercise, 2009) 
 There were 12 participants out of 67, with the majority in the ETC and ETK 
groups, with very small percentages of body fat (>3-5%); this may, in part, be due to the 
fact that most of the participants in the ETC and ETK groups, as well as some 
participants in the ACC and ACK groups, were trained endurance runners or involved in 
athletics requiring low body fat i.e. gymnastics, cheerleading, cycling. 
3.3 C-Reactive Protein 
 There were no significant interactions (p>0.05) with respect to all other outcome 
variables of biological inflammatory and immune markers with the exception of serum 
CRP.   The ETC group had a significant increase (p<0.05) in CRP levels following 
training as seen in Figure 12. There was no significant increase (p>0.05) in the level of 
CRP in the ETK, ACC or ACK groups.  A possible trend was observed for a kefir CRP 
interaction with the ETK and ACK groups experiencing percent increases in CRP 




Figure 12.  Effect of endurance training and kefir supplementation on serum C-reactive 
protein (mg/L). *Means for each bar differ significantly (P < 0.05). Data corresponds to 
the average ± SD of the results of subjects from 4 separate groups. Pre exercise training 
and post exercise training values were collected at the beginning and the conclusion of a 
15-week marathon training program. ETC=Exercise Training + Control Beverage; 
ETK=Exercise Training + Kefir Beverage; ACC=Active Control + Control Beverage; 
ACK= Active Control + Kefir Beverage. 
  
 The training program resulted in significantly increased (p<0.05) CRP levels in 
the ETC.  This increase could possibly be attributed to increased inflammation in the 
body due to the strenuous training regime. The CRP level in the ETK group following 
training was not significantly different than the initial CRP level.  The CRP level in the 
ETK group following training may indicate that supplementation with the kefir beverage 
could have a beneficial effect in regards to reducing the amount of exercise induced 
inflammation as measured by circulating CRP. The effect of exercise on CRP was 
examined by Stewart, et. al. in a 2007 study using active and previously inactive training 
groups.  Their results showed that both groups had a significant decline in serum CRP 
from pre- to post-training, with the most marked decrease in serum CRP (58%) occurring 
































exercising prior to this study in preparation for the endurance training which may have 
influenced a trend towards lower initial resting CRP levels.  
 Individuals with a level of serum CRP of <l mg/L a considered to be at low risk 
for cardiovascular disease (CVD), individuals with values from 1–3 mg/L at moderate 
risk and greater than 3 mg/L are at high risk for CVD (see Table. 4).  Based on these risk 
factors and the CRP means Pre and Post, we see a definite correlation between trained 
and untrained individuals in respect to overall risk for CVD. Average serum CRP 
concentrations in ACC both Pre and Post intervention (1.24 mg/L and 1.30 mg/L) were in 
the moderate-risk category.  Average value for the ACC group Pre intervention (0.944 
mg/L) was on the very high end of the low risk category, and the Post intervention 
average CRP level (1.15 mg/L) rose to the moderate risk category.  The ETC and ETK 
groups both had average CRP levels (ETC: 0.255 mg/L and 0.725 mg/L; ETK: 0.746 
mg/L and 0.588 mg/L) that started at and remained in the low risk for CVD category Pre 
and Post intervention.   
 These possible effects of kefir on attenuating CRP in s individuals participating in 
strenuous exercise programs may indicate a suppression of pro-inflammatory pathways 
caused by increased stress on the body.  Supplementation with kefir could also be 
stimulating an anti-inflammatory response and anti-oxidative pathways in participants 
following training which might also explain the lack of CRP elevation post-intervention 
in the ETK group. 
3.4 Tumor Necrosis Factor-α 
 There were no significant (p<0.05) interactions among groups with respect to 
levels of TNF-α.  The levels of TNF-α showed no significant (p<0.05) change between 
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samples collected Pre-intervention and Post-intervention within the treatment groups 
(Figure 13). 
 
Figure 13.  Effect of endurance training and kefir supplementation on TNF-α (pg/ml).  
There were no significant (p>0.05) differences in TNF-α found between treatment groups 
or pre-intervention and post-intervention. Blood samples were collected before and after 
completion of the training/intervention period. Data correspond to the average ± SD of 
the results of subjects from 4 separate groups. Pre exercise training and post exercise 
training values were collected at the beginning and the conclusion of a 15-week marathon 
training program.  ETC=Exercise    Training + Control Beverage; ETK=Exercise 
Training + Kefir Beverage; ACC=Active   Control + Control Beverage; ACK= Active 
Control + Kefir Beverage. 
 
 Previous studies examining the levels of soluble circulating TNF-a in plasma have 
yielded varying results. An average TNF-α of 5.7 for 24 women ages 19 to 39 was found 
in one study (Bullo, et. al., 2002) while another study including 307 women ages 19-49 
was reported a TNF-a 10.30 with values ranging from 5.45-19.86 (Himmerick, et. al., 
2006).  The normal value for college age active women and men is most likely reflected 
an average TNF-α level, as the levels of circulating TNF-α typically trend upward during 
aging (Bruunsgaard, et. al., 2002). 
 While some cytokines, such as interleukin-6, are strongly associated with CRP 


























weak (Tsukui, et. al., 2000).  This suggests that circulating levels of maybe influenced by 
a number of different factors and that circulating TNF-α levels may not reflect biologic 
activity at the tissue level.  Several studies have demonstrated significant increases in 
circulating cytokines, including TNF-α, when samples were collected immediately 
following strenuous activity (King, et. al., 2000; Bullo, et. al., 2002; Himmerich, et, al., 
2003).  The serum samples in this study were collected from rested participants having 
abstained from activity for 24 hour prior to collection, which may have been a factor in 
the failure of this study to demonstrate significant training effects of TNF-α.  Because the 
groups had no significant differences (p>0.05) in the level of TNF-α pre-intervention and 
post-intervention or between groups, no conclusions could be made regarding the effects 
of probiotics on attenuating the elevation expected following a high intensity training 
session. However, it has been shown that deleterious effects of TNF-alpha and IFN-
gamma on epithelial function can be prevented by probiotic treatment and the effect of 
bacteria on intestinal epithelial function may justify their use in inflammatory disorders 
(Resta-Lenert and Barrett, 2006). 
3.5 Frequency of Sickness and Injury  
 The total reported sicknesses are reported in Figure 14.  ETK (79 sicknesses) and 
ETC (64 sicknesses) had a much higher number of reported sicknesses than ACC (20 
sicknesses) and ACK (19 sicknesses) even though the sample sizes for ETC (n=10) and 
ETK (n=13) were much lower than ACC (n=21) and ACK (n=21).  The frequency of 
sickness was found to be significantly higher (p<0.05) in ETK and ETC as compared to 
ACK and ACC (Figure 14).  There were no significant differences found in frequency of 




Figure 14.  Total reported sickness during the 15-week intervention period. 
ETC=Exercise Training + Control Beverage; ETK=Exercise Training + Kefir Beverage; 
ACC=Active Control + Control Beverage; ACK= Active Control + Kefir Beverage; 
ET=ETC+ETK; AC=ACC+ACK 
   
 The average reported sicknesses (Table 13) of the ETC (6.4±4.08) and ETK 
(5.64±3.93) groups were significantly higher than the ACC (2.34±2.79) and ACK 
(1.31±1.16) groups due to well documented perturbations in immune functioning 
following intensive training.  
Table 13.  Average incidences of sickness for endurance training athletes and an active 
control consuming a kefir recovery beverage and a control beverage during a 15-week 
marathon training program. 













 abPairs not connected by a common letter are significantly different (p < 0.05).     
      ETC=Exercise Training + Control Beverage; ETK=Exercise Training + Kefir 
 Beverage; ACC=Active Control + Control Beverage; ACK= Active Control + 
 Kefir Beverage. 
 
 Many of the exercise-induced changes in immunity are similar to changes 
associated with other forms of stress, such as sleep deprivation, aging and psychological 
stress. Pederson, et. al. (2000) concluded that because the underlying mechanisms 






































neuroendocrinological and metabolic factors, nutritional supplementation may protect 
against the increased risk of infection in the recovery period after strenuous exercise.  If 
probiotics can improve immunity in athletes, then they may also be suitable for 
improving immunity in other individuals exposed to regular stress, such as the military 
and shift workers (Vinderola, 2004).  Results from this study indicate that while the 
instances of illness do indeed increase with an intensive training load, an a trend 
indicating possible attenuation of the severity or frequency of sickness in athletes could 
be, in part, due to the benefits incurred by kefir consumption. 
 The total reported injuries are reported in Figure 15.  ETK (70 injuries) and ETC 
(98 injuries) had a much higher number of injuries than ACC (20 injuries) and ACK (19 
injuries) even though the sample sizes for ETC (n=10) and ETK (n=13) were much lower 
than ACC (n=21) and ACK (n=21). 
 
 
Figure 15.  Total reported injury during the 15-week intervention period. ETC=Exercise 
Training + Control Beverage; ETK=Exercise Training + Kefir Beverage; ACC=Active 



































 The average number of reported injuries for ETC and ETK were significantly 
(p>0.05) higher than average number of injuries reported by ACC and ACK.  There were 
no significant differences found in frequencies of sickness and injury pre-intervention as 
compared to post-intervention between ETK and ETC or between ACK and ACC. 
Table 14.  Average number of injuries for endurance training athletes and an active 
control consuming a kefir recovery beverage and a control beverage during a 15-week 
marathon training program. 













     aPairs not connected by a common letter are significantly different (p < 0.05).   
     ETC=Exercise Training + Control Beverage; ETK=Exercise Training + Kefir     
     Beverage; ACC=Active Control + Control Beverage; ACK= Active Control + Kefir     
     Beverage. 
 
 The significantly higher (p<0.05) incidences of injury in the ETC and ETK 
groups as compared to the ACC and ACK groups (Table 14) was expected due to the 
increases likelihood of sport related injury accompanying long distance running 
programs. 
3.6 Athlete Burnout   
 The Athlete Burnout Questionnaire (ABQ) (Raedeke and Smith, 2001) consists of 
15 sport specific items with each question being “How often do you feel this way?” 
Athletes were asked to rate the extent to which they experienced each item in relation to 
their participation motives on a 5-point Likert scale with 1 = almost never to 5 = almost 
always (Appendix E).  The ABQ had three 5-item subscales assessing 3 key dimensions 
of burnout: Reduced sense of accomplishment (e.g., “It seems that no matter what I do, I 
don’t perform as well as I should”); Emotional and physical exhaustion (e.g., “I feel so 
tired from my training that I have trouble finding energy to do other things”); 
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Devaluation of sport participation (e.g., “The effort I spend participating in my sport 
would be better spent doing other things”).  
 There were no significant (p>0.05) interactions found among groups with respect 
to athlete burnout and attitudes about exercise and sport (Table 15). 
Table 15.  Three measures of athlete burnout in athletes and an active control consuming 
a kefir recovery beverage and a control beverage during a 15-week endurance training 
program. 

















Three 5-item subscales in the Athlete Burnout Questionnaire assessing 3 key dimensions 
of burnout were used. There were no significant (p>0.05) differences in the athlete 
burnout measures found between treatment groups. Values are reported as mean value of 
participation motives on a 5-point Likert scale with 1 = almost never to 5 = almost 
always. ETC=Exercise Training + Control Beverage; ETK=Exercise Training + Kefir 
Beverage; ACC=Active Control + Control Beverage; ACK= Active Control + Kefir 
Beverage. 
 
 The three measures of athlete burnout (Emotional and Physical Exhaustion, Sense 
of Accomplishment, Sport Devaluation) showed no significant (p>0.05) differences 
between the four treatment groups or between the training participants (ETC and ETK 
combined) and the exercise controls (ACC and ACK combined).  
 “Overtraining” is defined by Buggett (1998) as “a non-deliberate long-term 
decrement in performance capacity resulting from a failure to recover adequately from an 
accumulation of training and non-training stress”.  It is common for elite athletes, 
especially young and inexperienced competitors, to “push themselves too far, overreach, 
constantly experience extreme tiredness on a regular basis and never realize their full 
potential or achievement capability (Gould and Dieffenbach, 2002).  In athletes, burnout 
can be a result of excessive training and insufficient recovery following training.  
Kellman (2002) describes this type of overreaching as a deliberate part of the training and 
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recovery process needed to achieve desired performances, with performance 
incompetence being a temporary effect (Lehmann, et. al., 1999). This short-term lowered 
performance capacity state can be restored with the help of a brief recovery period 
(Meeusen, et. al., 2006).  In contrast to functional overreaching, non-functional 
overreaching e.g. overtraining often results in athlete burnout due to a combination of 
excessive overload and inadequate recovery and can lead to severe psychological and 
physiological symptoms.  Because no significant differences were observed in ABQ 
scores between ETC and ETK and no burnout was observed, the beverages provided to 
the athletes may have aided in recovery and preventing burnout due to overtraining. 
3.7 Consumer Survey and Sensory Analysis  
 In all groups, the vast majority of participants believed that food would aid in 
recovery following exercise, with only 4 participants in the AC groups (ACC and ACK) 
responding “not sure”.  When asked how long following exercise food is typically 
consumed, responses were varied, with most reporting eating within an hour following 
exercise, and, when asked what they ate at that time, the two most common responses 
were “smoothie” and “shake”, as reported by 23 of the total 67 participants.  Other 
common responses were “gatorade/powerade” (4 responses), “granola bar” (3 responses) 
and “dinner” (3 responses).  Four participants in the ET group (n=25) and 5 participants 
in the AC group (n=42) reported consumption of dairy products (milk, yogurt, whey 
protein) following exercise. 
  Based on responses to questions regarding preexisting post-exercise recovery 
programs with a food component, information regarding current exercise practice and 
implementation of a recovery program was assessed.  The majority of participants in all 
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groups reported that they were currently exercising at moderate intensity at least 2 times 
per week.   Five participants in the ET groups (n=25) and 7 out of the AC groups (n=42) 
were following an exercise recovery program.  For the participants using food to aid in 
exercise recovery, common responses were “smoothie” and “protein shake” (23 
responses).   
 Prior to participation in this study, only 6 participants had heard of kefir (N=67), 
and 2 individuals had previously consumed kefir.  Finally, the participants were asked 
about current yogurt and other fermented milk consumption with the response choices 
being: Never, Once a week, Two times a week, and More than two times per week (Table 
16). 
Table 16.  Reported consumption of yogurt and other fermented dairy products by college 
students (age 18-30 yrs) participating in a marathon-training program and an active 
control.           
Treatment 
group 


























Total (N=67) 19 24 10 20 
  ETC=Exercise Training + Control Beverage; ETK=Exercise Training + Kefir Beverage;    
  ACC=Active Control + Control Beverage; ACK= Active Control + Kefir Beverage. 
 
 The goals of the participant survey component of this research were to provide 
insight into the perceptions of the role of nutrition in exercise and current dietary 
practices in college students and student athletes especially as they relate to dairy foods.  
From these results, it is clear that the majority of the college students participating in this 
study have limited knowledge regarding recovery from exercise and sport nutrition.  
Although there were a few students in the ETK and ETC using dairy products (milk or 
yogurt) as part of a recovery program involving food, the introduction of a dairy food 
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following exercise was a new recovery implement for a large majority of participants.  
The reported rates of fermented dairy consumption indicated that 30% of the participants 
were consuming more than 2 servings per week.  The majority (51%) of the participants 
reported yogurt consumption once or twice a week, and the remainder 29% reported no 
consumption of fermented dairy products. 
 Results of the product evaluation survey are reported in Figure 17.  No significant 
differences (p<0.05) were found between the kefir beverage and the control beverage for 
any of the sensory attributes.  This indicates that the control beverage was successfully 
matched to the kefir beverage in regards to flavor, texture, appearance and overall 
acceptability, which was necessary to maintain the subject blinded experimental design. 
 
Figure 16.  Sensory analysis of kefir recovery beverage and control.  
 The overall acceptance and perceived benefits of the recovery beverages provided 
was assessed in an exit survey (Table 17).  Results indicate a very positive response to 
both beverages overall indicating that majority of participants would buy this product 



















Table 17.  Product acceptability and consumer intent of purchase for a kefir based post-
exercise recovery beverage and a control beverage by athletes participating in a 15-week 
marathon training program and an active control. 








Did consuming this 
product following 
exercise aid in 
recovery? 
          
Kefir beverage 
Control 























 Due to problems encountered with the Secretory IgA Enzyme-Linked-Immuno-
Assay test kit (Salimetrics, State College, PA), many of the saliva samples needed to be 
reanalyzed.  However, there was not enough saliva supernatant to complete the sIgA 
assay; therefore, no results are available for average sIgA levels for the treatment groups. 
The donation of blood samples from the study participants was not compulsory and 
several students from each group did not participate in this portion of the research; in 
addition, three students who gave blood at the beginning of the experimental period did 
not participate in the post intervention period, and although all groups maintained a size 
of n=8, this lowered sample size could have influenced the results of the statistical 
analysis, especially because of the high degree of deviation between the participants 
within each group. Because a relatively small sample size was collected for testing the 
number of assays performed per participant sample was limited.   Several samples that 
needed to be re-run due to higher than expected CVs of duplicate samples were 
unavailable for subsequent assays; the number of samples in the ETC and ETK groups 
dropped to 6 and 7, respectively.  The sample size limitations prevented valid statistical 
analysis of these groups for sIgA.  ELISA methods are useful because they provide high 
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specificity and good standardizability between and within assays. Unfortunately, cytokine 
assay results may vary due to the methods used for cytokines detection and their 
sensitivities, interferences due to different drugs used, and the effect of concomitant 
pathologies (Szegedi, et. al. 2003). 
 Compliance with and beverage consumption was not a major issue. However, 
although instructed not to discuss beverage, several participants did compare sensory 
aspects such as levels of sweetness and color and made attempts to determine which 
beverage (kefir or control) they were consuming.  One subject was removed from the 
study due to 3 missed beverage treatments. Adherence to the training protocol also 
proved challenging for several participants in the ETK and ETC groups.  
 For this project, the inability to control for variables such as consumption of other 
fermented foods or probiotics and other dietary components may have had influenced the 
action of the probiotics.  Excessive caffeine and alcohol use has also been shown to have 
deleterious effects on training, as they can prevent proper rehydration due to increased 
diuresis (Burke, et. al., 1997).  However, the effect of probiotics on alcohol consumption 
and gut homeostasis has demonstrated some interesting results.  In a 2009 study by 
Forsyth, et. al., rats were gavaged with alcohol twice daily for 10 weeks; the alcoholic 
rats were also treated with once daily gavage of either 2.5 × 107 live L. 
rhamnosus Gorbach–Goldin (LGG) or vehicle (V). They found that reduced alcohol-
induced gut leakiness and significantly blunted alcohol-induced oxidative stress and 
inflammation in both intestine and the liver. Another similar study found that Short-term 
oral supplementation with B. bifidum and L. plantarum 8PA3 was associated with 
restoration of the altered bowel flora and the frequency of endotoxemia associated with 
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chronic alcohol consumption and demonstrated an improvement in alcohol-induced liver 
injury (Kirpich, et. al., 2008). 
  A wash out period A group of participants instructed not to consume probiotics 
containing foods for a certain period of time leading up to the intervention i.e. wash out 
period, or a group of subjects not regularly consuming probiotics or diary products would 
have better elucidated the probiotic effects of kefir in combination with a training 
intervention.  In addition, a water control for baseline measurements and would 
especially help to determine if the consumption this product versus no recovery food 
would have a significant effect; however, a third treatment group (water only) was not 
possible due to low subject numbers.   
 This research protocol did not control for antibiotic use by the participants during 
illness.  Although antibiotic use was not reported by the participants, there was most 
likely prevalent antibiotic use, especially in the ETC and ETK groups as they had many 
more instances of sickness as compared to the control.  The dosage, type and time 
receiving antibiotics needed to be assessed to determine the existence of any interactive 










CHAPTER 4.  CONCLUSIONS AND FUTURE WORK 
 This study demonstrates the potential for a kefir recovery beverage as an 
appealing source of nutrients and probiotics for athletes as an exercise recovery beverage 
and for non-athletes as a healthful food product.  The significant reduction of milk sugars 
by lactic acid bacteria and yeasts during fermentation and the breakdown of proteins into 
bioactive peptides and free amino acids most likely increased digestibility, as the 
beverage was well tolerated by all of the athletes following intense exercise.  The milk 
based sports recovery drinks in the present market are processed to increase shelf life and 
to remove lactose; however, the development of an all natural, minimally processed 
beverage formulated with naturally occurring probiotics will provide athletes of all ages 
and skill levels with a healthy alternative to other currently available products.   
 The effects of kefir on CRP levels in athletes and how this translates to the 
mediation of inflammation and immunity via changes in gut health by using keifr 
following intense activity may aid in understanding the role of probiotics and other 
fermented foods as they relate to human health. Results of this study suggest that 
supplementation with kefir during intensive exercise training could possibly attenuate 
symptoms or reduce instances of some of the negative side-effects of exercise by helping 
to regulate the damage caused by inflammation and oxidative stress.   
 An important next step in understanding the mechanisms involved in the 
immunomodulating and anti-inflammatory effects of consuming kefir following activity 
will be further characterization of gut microbiota of various exercising populations, 
including individuals with diseases such as cancer and diabetes. Using genomic 
sequencing to determine if any significant variations exist in the gut microflora between 
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subjects consuming kefir post-exercise would further elucidate the effects and possible 
uses of kefir in training, recovery and maintenance of optimal health. Another necessity 
would be exploration into the relationship between other bioactive components in milk, 
particularly those found in fermented milks, such as bacteriocins, organic acids and 
exopolysaccharides, and human health. 
 Improvement and innovation of processing techniques for fermented products, 
with an emphasis on new packaging strategies for dairy products containing live, active 
cultures will be crucial for the success of this product on a larger scale. The design of a 
packaging system for fluid dairy products containing heterofermentative bacteria and 
yeasts allowing a controlled release of excess gas while maintaining a level of 
carbonation in the product will be required for a recovery beverage of this type to be 
successful in the current food market. In, summary, this study provided useful 
information regarding acceptability of a kefir based post-exercise recovery beverage by 
athletes and demonstrated an attenuation of exercise induced inflammation following 
kefir consumption. Continued exploration of the therapeutic properties of kefir as it 
relates to achieving and maintaining optimal health during athletic training will be 
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APPENDIX C – CONSENT FORMS                                                                                
2.2 Participant Consent Form – Explanation of Research Protocols 
Participant Consent Form 
1. Study Title: The Effects of Post Exercise Consumption of a Fermented Milk Beverage 
on Performance and Recovery During Intensive Endurance Training  
2. Performance Site: Louisiana State University Baton Rouge, LA 70803  
3. Investigators: The following investigators are available for questions about this study, 
M-F, 8:00 a.m.- 4:30 p.m.  Principle Investigator: Charles Boeneke, Ph.D. 225-
578-4383 Co-investigators: Keely O’Brien. M.S. 225-578-4382  Laura K. 
Stewart, Ph.D. 225-578-3549  
4. Purpose of the Study:  The purpose of this research project is to examine the effects of 
post workout supplementation with a milk beverage on subjects participating in a 
15-week intensive marathon training program.  
5. Subject Inclusion:  Participants in the control and training groups must be at least 18 
years of age and currently enrolled students or are employees at LSU. Subjects in 
the training group must have medical clearance following a complete 
comprehensive physical from a state licensed M.D or D.O. The cleared student 
must provide documentation of permission by returning a signed “Physician 
Approval Form” after the physical and before participating in the study. Students 
in the active control group must complete a physical activity readiness 
questionnaire (PAR-Q) before participating.  You must be healthy and between 
the ages of 18-35 years. General exclusion criteria for all subjects are as follows: 
the presence of disease conditions including diabetes, cardiovascular disease, 
cancer, HIV, asthma, resting blood pressure > 160/100mmHg, hospitalization 
within the last 6 months, plans to be away for more than 2 weeks in the next 9 
months, significant weight loss in the past year (> 20 kg) or current use of weight 
loss medications, being pregnant or planning to become pregnant within the next 
6 months.  Information regarding product ingredients and possible allergens will 
be provided to you; subjects with allergies or sensitivities to product ingredients 
will be excluded.  
6. Number of subjects= 
Milk beverage 1 + marathon training group: n=20 Milk beverage 2 + marathon training 
group: n=20 
Milk beverage 1 + active control: n=20 Milk beverage 2 + active control: n=20 
Total: N=80 7. Study Procedures: 
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Product Development and Manufacture: Products will be manufactured in the LSU 
Creamery, a licensed dairy processing facility. 
Baseline: Before the 13 week training program begins, you will have baseline 
measurements taken. This will include basic baseline measurements such as body weight, 
height, waist hip ratio, resting metabolic rate and blood sample collection. An assessment 
of your physical fitness will be estimated by having you perform a 1.5 mile run/walk test. 
This test will require you to complete 1.5 miles at a maximal effort. A physical fitness 
questionnaire will be administered and a dietary log will be kept for one week prior to the 
start of the program. An ingredient list will be provided to you prior to consumption of 
the product to make you aware of any possible allergens and a product liability waiver 
will be collected. 
13 Week Intervention Program: At the start of the program, you will be provided with a 
suggested training program (training group only). If you choose not to follow this training 
program, you will not be penalized. Twice weekly you will be given a 12-ounce portion 
of a smoothie type beverage. Throughout the 15-week training period, both groups will 
fill out a training log. This should take about 20 minutes weekly to complete. Participants 
in the active control group will be instructed to continue their own personal training 
programs and participants in both groups will continue to complete weekly training and 
diet logs, and sickness inventory questionnaires. 
Post-Training: One week prior to the marathon event, you will undergo post-training 
measures. Procedures for post-training measurements will be identical to the protocol 
followed for preliminary measures. 
8. Benefits: 
While no guarantee of benefits can be made, you will be given training and nutrition 
instruction and a body composition analysis at no cost to you. You may also learn more 
about your physical capacity for endurance and should significantly improve your aerobic 
fitness. Subjects will be provided a comparison of his/her pre-training and post-training 
results at the end of the semester. An optional paid blood collection will be given with 
$25 being paid following each of a total of two collections. 
9. Risks/Discomforts: 
Product Consumption: As with any food product, there is a chance that you may have 
certain allergies or food sensitivities to ingredients included in the product. All 
ingredients will be disclosed to you prior to consumption of the product to alert you of 
any potential health concerns regarding food allergens. You will be required to sign a 
waiver acknowledging that you have been informed of this risk prior to the consumption 
of the product. 
Exercise Training & Testing: As with any exercise program, there is a chance that you 
will experience muscle soreness, fatigue, or even injuries such as sprains or strains. There 
is also a remote risk of a heart attack or stroke and in very rare cases, death. Precautions 
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to minimize this risk have been taken by requiring medical clearance to participate as 
well as completion of a health history questionnaire. Your cooperation in obtaining 
approval from your physician as well as providing honest answers in completing the 
health history form will decrease this risk. 
Plasma and Whole Venous Blood Collection: There is risk of bruising and soreness at the 
site of blood collection, and the remote risk of fainting. 
In addition to the risks listed above, you may experience a previously unknown risk 
or side effect. 
10. Injury/Illness: In the unlikely event of injury or medical illness resulting from the 
above procedures, contact Laura Stewart, Ph.D., 225-578-3549. You will 
be referred for treatment, but the expense of medical treatment will be your 
responsibility. No compensation is available in case of study-related illness or 
injury.  
11. Right to Refuse: You may choose not to participate or to withdraw from the study 
at any time without penalty; however there will be a loss of any benefit to which 
you might otherwise be entitled, including monetary compensation for blood 
sample collection.  
12. Privacy: Your identity will remain confidential unless disclosure is required 
by law. In other words, data will be kept confidential unless release is legally 
compelled. All data collected will be handled only by the investigators and kept in 
a secure location. Results of the study may be published using group means only 
and names or identifying information will not be included in the publication.  
13. Financial Information: There is no cost to you, and compensation will be given if 
you  
participate in the blood collection portion of the study. $25 will be paid following each 
sample collection. 
14. Signatures: The study has been discussed with me and all my questions have been 
answered. I may direct additional questions regarding study specifics to the investigators. 
If I have any questions about subjects’ rights or other concerns, I can contact Robert C. 
Matthews, Institutional Review Board at (225) 578-8692. I agree to participate in the 
study described above and acknowledge the investigator’s obligation to provide me with 
a signed copy of this consent form. 
___________________ Participant’s Signature Date 
___________________ Witness Signature Date 
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2.3 Physician Approval Form for Participation in Marathon Training  
 
Physician Approval Form 
Kinesiology 4526 
The Physiology of Endurance Training 
 
*This physical must be completed by a Louisiana State licensed M.D. or D.O. only* 
 
 
 I have completed a full comprehensive physical examination of _____________________ (print 
student’s full name) as required for him/her to participate in Kinesiology 4526 (The Physiology of 
Endurance Training).  I understand that the student will be engaging in an intensive running and 
conditioning program which will involve optional participation in a course-designated Marathon 
during the Spring 2012 semester. Based on my physical findings, I am making the following 
recommendation related to the demands of the course: 
 
____ Patient is cleared to participate without restriction. 
____ Patient is cleared to participate with the following restrictions or guidelines.  
__________________________________________________________________ 
_____ Patient is not cleared to participate. 
 
Physician Signature: _________________________________________________ 






If there are questions or concerns, please contact: 
Laura K. Stewart, Ph.D. 
Department of Kinesiology 
112 Long Fieldhouse  
Louisiana State University 
Baton Rouge, LA 70803 
Phone: 225.578.3549 
Fax:  225.578.3680 
stewart6@lsu.edu 
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No changes permitted. You are encouraged to photocopy the PAR-­Q but only if you use the entire form.
1.    Has your doctor ever said that you have a heart condition and that you should only do physical activity 
recommended by a doctor?
2.    Do you feel pain in your chest when you do physical activity?
3.    In the past month, have you had chest pain when you were not doing physical activity?
4.    Do you lose your balance because of dizziness or do you ever lose consciousness?
5.    Do you have a bone or joint problem (for example, back, knee or hip) that could be made worse by a 
change in your physical activity?
6.    Is your doctor currently prescribing drugs (for example, water pills) for your blood pressure or heart con-­
dition? 
7.    Do you know of any other reason why you should not do physical activity?
PLEASE NOTE:  If  your health changes so that you then answer YES to 
any of  the above questions, tell your fitness or health professional.  
Ask whether you should change your physical activity plan.
Regular physical activity is fun and healthy, and increasingly more people are starting to become more active every day.  Being more active is very safe for most 
people. However, some people should check with their doctor before they start becoming much more physically active.
If  you are planning to become much more physically active than you are now, start by answering the seven questions in the box below.  If  you are between the 
ages of  15 and 69, the PAR-Q will tell you if  you should check with your doctor before you start.  If  you are over 69 years of  age, and you are not used to being 
very active, check with your doctor.
Common sense is your best guide when you answer these questions.  Please read the questions carefully and answer each one honestly:  check YES or NO.
Talk with your doctor by phone or in person BEFORE you start becoming much more physically active or BEFORE you have a fitness appraisal.  Tell 
your doctor about the PAR-Q and which questions you answered YES.
•  You may be able to do any activity you want — as long as you start slowly and build up gradually.  Or, you may need to restrict your activities to 
those which are safe for you. Talk with your doctor about the kinds of  activities you wish to participate in and follow his/her advice.




Questionnaire - PAR-Q 
(revised 2002)
DELAY BECOMING MUCH MORE ACTIVE:
•  if  you are not feeling well because of  a temporary illness such as 
a cold or a fever – wait until you feel better; or
•  if  you are or may be pregnant – talk to your doctor before you 




If  you answered NO honestly to all PAR-Q questions, you can be reasonably sure that you can:
•  start becoming much more physically active – begin slowly and build up gradually.  This is the 
safest and easiest way to go.
•  take part in a fitness appraisal – this is an excellent way to determine your basic fitness so 
that you can plan the best way for you to live actively. It is also highly recommended that you 
have your blood pressure evaluated.  If  your reading is over 144/94, talk with your doctor 
before you start becoming much more physically active.
NOTE:  If  the PAR-Q is being given to a person before he or she participates in a physical activity program or a fitness appraisal, this section may be used for legal or administrative purposes.
"I have read, understood and completed this questionnaire.  Any questions I had were answered to my full satisfaction."
NAME ________________________________________________________________________         
SIGNATURE _______________________________________________________________________________            DATE______________________________________________________
SIGNATURE OF PARENT _______________________________________________________________________            WITNESS ___________________________________________________
or GUARDIAN (for participants under the age of  majority)
Informed Use of  the PAR-Q:  The Canadian Society for Exercise Physiology, Health Canada, and their agents assume no liability for persons who undertake physical activity, and if  in doubt after completing 
this questionnaire, consult your doctor prior to physical activity.
continued on other side...
(A Questionnaire for People Aged 15 to 69)
   YES         NO
YES to one or more questions
NO to all questions
Note:  This physical activity clearance is valid for a maximum of 12 months from the date it is completed and 
becomes invalid if your condition changes so that you would answer YES to any of the seven questions.
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APPENDIX E – RECURRING SURVEYS 









Age______________	  	  	  	  	  Sex____________	  	  	  	  Height_______________	  	  Weight________________	  
	  
	  








	   	  
	   Male:	  
	   	  
	   Chest	  ______________	  	  	  	  	  	  	  	  	  _______________	  	  	  	  	  	  	  	  _________________	  
	   	  
	   	  
	   Abdominal	  	  ______________	  	  	  	  	  	  	  	  	  _______________	  	  	  	  	  	  	  	  _________________	  	  
	   	  
	   	  
	   Thigh	  	  	  	  	  	  	  	  	  	  	  	  	  ______________	  	  	  	  	  	  	  	  	  _______________	  	  	  	  	  	  	  	  _________________	  
	   	  	  
	   	  
	   Female:	  
	  
	   Triceps	  	  	  	  	  	  	  	  	  ______________	  	  	  	  	  	  	  	  	  _______________	  	  	  	  	  	  	  	  	  _________________	  
	   	  
	   	  
	   Suprailiac	  	  	  	  	  ________________	  	  	  	  	  	  	  	  	  _______________	  	  	  	  	  	  	  	  _________________	  
	   	  
	   	  




Blood	  collection	  ____________	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APPENDIX E – RECURRING SURVEYS 





ID _________       Date____________  
       
Weekly Self-Report Injury Questionnaire 
Use this log to record any injury which you may have experienced during the past week of 
training.  Record the severity score (1-4) and the impact score (A-D) by each symptom in the 
column corresponding to the date.  
INJURY DATE DATE DATE DATE DATE DATE DATE DATE 
Shin	  Splints	           
Patellofemoral syndrome         
Pulled hamstring         
IT Band syndrome         
Ankle Sprain         
Plantar Fasciitis         
Achilles Tendonitis         
Arch Pain         
Knee Pain         
Hip Pain         
Groin Pain         
Blisters         
Other:         
Did you visit the doctor?  
Yes/No 
        
Were there changes in your 
daily routine? Yes/No 
        
Was your training affected by 
the injury?  Yes/No 
















APPENDIX E – RECURRING SURVEYS 
4.3 Weekly Sickness Self-Assessment Questionnaire 
 
  Weekly Respiratory Symptom Self-Assessment Questionnaire  
          
1. Use your daily respiratory symptom self-assessment questionnaire to summarize the following 
symptoms which you may or may have not have experienced within the last week.  Record the 
severity score (1-4) and the impact (A-D)  by each symptom in the column corresponding to the 
date.   *For example:  insert a “2, B” in column “11/10”  row “cough” if on the 10th of   
   November you experienced a mild cough that reduced the time or distance of  
   your activities.   
 
Symptom DATE DATE DATE DATE DATE DATE DATE DATE 
Cough         
Sneezing         
Sore Throat         
Nasal Discharge         
Stuffy Nose         
Headache         
Tiredness         
Chilliness         
Shaking Chills         
Fever         
Hoarseness         
Aching muscle or joints         
Watery or burning eyes.           
         
Did you visit the doctor?  
Yes/No 
        
Were there changes in your daily 
routine? Yes/No 
        
Was your training effected by 
illness?  Yes/No 
        
 
2.  Please report the number of hours spent training and the average intensity in each of the following 
activities during the past week.   
a.  =  low intensity, easy workouts 
b.  =  moderate intensity, moderate workouts 
c.  =  high intensity, intense workout 
 
 
Mode of Activity Weekly Training Time Average Intensity of Training 
Swimming   
Cycling   
Running   
Other Physical Activities   
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APPENDIX E – RECURRING SURVEYS 
4.4 Athlete Burnout Questionnaire (ABQ) 
 
Date: ________________  ID:_________ 
 
 
Please read each statement carefully and rate how often you experienced each item since 
the last week. Substitute your specific sport (e.g., marathon training/running) when 





• Reduced sense of accomplishment: 1(REV), 5, 7, 13, 14(REV) 
• Emotional/Physical exhaustion: 2, 4, 8, 10, 12, 
• Devaluation: 3, 6, 9, 11, 15 


















always      Statements: 
1.  I’m accomplishing many worthwhile things in [sport]. 1 2 3 4 5 
2.  I feel so tired from my training that I have trouble finding energy to 
do other things. 1 2 3 4 5 
3.  The effort I spend in [sport] would be better spent doing other things. 1 2 3 4 5 
4.  I feel overly tired from my [sport] participation. 1 2 3 4 5 
5.  I am not achieving much in [sport].  1 2 3 4 5 
6.  I don’t care as much about my [sport] performance as I used to. 1 2 3 4 5 
7.  I am not performing up to my ability in [sport].  1 2 3 4 5 
8.  I feel “wiped out” from [sport]. 1 2 3 4 5 
9.  I am not into [sport] like I used to be. 1 2 3 4 5 
10. I feel physically worn out from [sport]. 1 2 3 4 5 
11. I feel less concerned about being successful in [sport] than I used to. 1 2 3 4 5 
12. I am exhausted by the mental and physical demands of [sport]. 1 2 3 4 5 
13. It seems that no matter what I do, I don’t perform as well as I should. 1 2 3 4 5 
14. I feel successful at [sport]. 1 2 3 4 5 
15. I have negative feelings toward [sport]. 1 2 3 4 5 
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APPENDIX F – SENSORY EVALUATION FORMS 
5.1 Preliminary Sport Nutrition Survey  
 
ID________________________   Date___________________________     









2.  How long after exercise do you eat or drink anything other than water? 
   
             0-30 minutes         30-60 minutes          60-90 minutes        >90 minutes 

























8.  How often do you consume yogurt or other fermented dairy products (such as sour cream, 
 buttermilk, kefir, etc.)? 
 
            Never                       Once a week               Two times a week       More than two times per week 
               (   )                                  (   )                                     (   )                                          (   ) 
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APPENDIX G – RAW DATA 




Oneway Analysis of Sickness By GROUP 
 Oneway Anova 
Summary of Fit 
Rsquare 0.360867 
Adj Rsquare 0.330432 
Root Mean Square Error 2.918949 
Mean of Response 3.179104 
Observations (or Sum Wgts) 67 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
GROUP 3 303.07412 101.025 11.8570 <.0001* 
Error 63 536.77662 8.520   
C. Total 66 839.85075    Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
ACC 21 2.14286 0.63697 0.870 3.4157 
ACK 22 1.13636 0.62232 -0.107 2.3800 
ETC 10 6.40000 0.92305 4.555 8.2446 
ETK 14 5.64286 0.78012 4.084 7.2018 
Std Error uses a pooled estimate of error variance 
Means Comparisons 




LSD Threshold Matrix 
Abs(Dif)-HSD 
 ETC ETK ACC ACK 
ETC -3.4449 -2.4322 1.2976 2.3258 
ETK -2.4322 -2.9114 0.8422 1.8730 
ACC 1.2976 0.8422 -2.3772 -1.3435 
ACK 2.3258 1.8730 -1.3435 -2.3225 
Positive values show pairs of means that are significantly different. 
Connecting Letters Report 
Level       Mean 
ETC A      6.4000000 
ETK A      5.6428571 
ACC  B     2.1428571 
ACK  B     1.1363636 
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Levels not connected by same letter are significantly different. 
Ordered Differences Report 
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value  
ETC ACK 5.263636 1.113244 2.32584 8.201433 <.0001*  
ETK ACK 4.506494 0.997935 1.87299 7.139998 0.0002*  
ETC ACC 4.257143 1.121496 1.29757 7.216718 0.0018*  
ETK ACC 3.500000 1.007133 0.84222 6.157777 0.0050*  
ACC ACK 1.006494 0.890512 -1.34353 3.356512 0.6724  
ETC ETK 0.757143 1.208560 -2.43219 3.946475 0.9232   
Oneway Analysis of Injury By GROUP 
 Oneway Anova 
Summary of Fit 
Rsquare 0.528986 
Adj Rsquare 0.506557 
Root Mean Square Error 2.720064 
Mean of Response 3.283582 
Observations (or Sum Wgts) 67 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
GROUP 3 523.49073 174.497 23.5846 <.0001* 
Error 63 466.12121 7.399   
C. Total 66 989.61194    Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
ACC 21 0.95238 0.59357 -0.234 2.1385 
ACK 22 1.45455 0.57992 0.296 2.6134 
ETC 10 6.50000 0.86016 4.781 8.2189 
ETK 14 7.35714 0.72697 5.904 8.8099 
Std Error uses a pooled estimate of error variance 
Means Comparisons 




LSD Threshold Matrix 
Abs(Dif)-HSD 
 ETK ETC ACK ACC 
ETK -2.7131 -2.1149 3.4485 3.9281 
ETC -2.1149 -3.2102 2.3078 2.7897 
ACK 3.4485 2.3078 -2.1643 -1.6877 
ACC 3.9281 2.7897 -1.6877 -2.2152 
Positive values show pairs of means that are significantly different. 
Connecting Letters Report 
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Level       Mean 
ETK A      7.3571429 
ETC A      6.5000000 
ACK  B     1.4545455 
ACC  B     0.9523810 Levels not connected by same letter are significantly different. 
Ordered Differences Report 
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value  
ETK ACC 6.404762 0.938511 3.92808 8.881449 <.0001*  
ETK ACK 5.902597 0.929940 3.44853 8.356666 <.0001*  
ETC ACC 5.547619 1.045082 2.78970 8.305541 <.0001*  
ETC ACK 5.045455 1.037392 2.30783 7.783082 <.0001*  
ETK ETC 0.857143 1.126214 -2.11488 3.829167 0.8716  
ACK ACC 0.502165 0.829836 -1.68773 2.692063 0.9301   
Oneway Analysis of Emotional Physical Exhaustion By GROUP 
 Oneway Anova 
Summary of Fit 
Rsquare 0.026843 
Adj Rsquare -0.0195 
Root Mean Square Error 0.637305 
Mean of Response 1.895513 
Observations (or Sum Wgts) 67 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
GROUP 3 0.705810 0.235270 0.5793 0.6308 
Error 63 25.587945 0.406158   
C. Total 66 26.293756    Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
ACC 21 1.80062 0.13907 1.5227 2.0785 
ACK 22 1.90433 0.13587 1.6328 2.1759 
ETC 10 1.82154 0.20153 1.4188 2.2243 
ETK 14 2.07683 0.17033 1.7365 2.4172 
Std Error uses a pooled estimate of error variance 
Means Comparisons 




LSD Threshold Matrix 
Abs(Dif)-HSD 
 ETK ACK ETC ACC 
ETK -0.63567 -0.40248 -0.44104 -0.30407 
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ACK -0.40248 -0.50709 -0.55863 -0.40938 
ETC -0.44104 -0.55863 -0.75213 -0.62526 
ACC -0.30407 -0.40938 -0.62526 -0.51902 
Positive values show pairs of means that are significantly different. 
Connecting Letters Report 
Level       Mean 
ETK A      2.0768348 
ACK A      1.9043282 
ETC A      1.8215385 
ACC A      1.8006216 Levels not connected by same letter are significantly different. 
Ordered Differences Report 
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value  
ETK ACC 0.2762132 0.2198912 -0.304069 0.8564956 0.5939  
ETK ETC 0.2552964 0.2638694 -0.441042 0.9516352 0.7683  
ETK ACK 0.1725066 0.2178830 -0.402476 0.7474895 0.8579  
ACK ACC 0.1037066 0.1944288 -0.409382 0.6167951 0.9506  
ACK ETC 0.0827898 0.2430587 -0.558630 0.7242100 0.9863  
ETC ACC 0.0209169 0.2448604 -0.625258 0.6670920 0.9998   
Oneway Analysis of Sense of Accomplishment By GROUP 
 Oneway Anova 
Summary of Fit 
Rsquare 0.049931 
Adj Rsquare 0.004689 
Root Mean Square Error 0.555059 
Mean of Response 2.046499 
Observations (or Sum Wgts) 67 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
GROUP 3 1.020070 0.340023 1.1036 0.3543 
Error 63 19.409690 0.308090   
C. Total 66 20.429761    Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
ACC 21 1.91513 0.12112 1.6731 2.1572 
ACK 22 2.16795 0.11834 1.9315 2.4044 
ETC 10 1.91078 0.17553 1.5600 2.2615 
ETK 14 2.14964 0.14835 1.8532 2.4461 
Std Error uses a pooled estimate of error variance 
Means Comparisons 






LSD Threshold Matrix 
Abs(Dif)-HSD 
 ACK ETK ACC ETC 
ACK -0.44165 -0.48246 -0.19405 -0.30147 
ETK -0.48246 -0.55363 -0.27089 -0.36762 
ACC -0.19405 -0.27089 -0.45204 -0.55844 
ETC -0.30147 -0.36762 -0.55844 -0.65507 
Positive values show pairs of means that are significantly different. 
Connecting Letters Report 
Level       Mean 
ACK A      2.1679540 
ETK A      2.1496387 
ACC A      1.9151293 
ETC A      1.9107809 Levels not connected by same letter are significantly different. 
Ordered Differences Report 
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value  
ACK ETC 0.2571731 0.2116911 -0.301470 0.8158160 0.6198  
ACK ACC 0.2528247 0.1693372 -0.194048 0.6996974 0.4477  
ETK ETC 0.2388578 0.2298162 -0.367616 0.8453319 0.7271  
ETK ACC 0.2345094 0.1915135 -0.270886 0.7399044 0.6138  
ACK ETK 0.0183153 0.1897645 -0.482464 0.5190948 0.9997  
ACC ETC 0.0043484 0.2132604 -0.558436 0.5671325 1.0000   
Oneway Analysis of Sport Devaluation By GROUP 
 Oneway Anova 
Summary of Fit 
Rsquare 0.085363 
Adj Rsquare 0.041809 
Root Mean Square Error 0.637774 
Mean of Response 1.772923 
Observations (or Sum Wgts) 67 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
GROUP 3 2.391639 0.797213 1.9599 0.1291 
Error 63 25.625606 0.406756   
C. Total 66 28.017245    Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
ACC 21 1.64727 0.13917 1.3692 1.9254 
ACK 22 2.04300 0.13597 1.7713 2.3147 
ETC 10 1.64195 0.20168 1.2389 2.0450 
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ETK 14 1.63055 0.17045 1.2899 1.9712 
Std Error uses a pooled estimate of error variance 
Means Comparisons 




LSD Threshold Matrix 
Abs(Dif)-HSD 
 ACK ACC ETC ETK 
ACK -0.50746 -0.11773 -0.24084 -0.16295 
ACC -0.11773 -0.51940 -0.64133 -0.56399 
ETC -0.24084 -0.64133 -0.75269 -0.68545 
ETK -0.16295 -0.56399 -0.68545 -0.63614 
Positive values show pairs of means that are significantly different. 
Connecting Letters Report 
Level       Mean 
ACK A      2.0430017 
ACC A      1.6472694 
ETC A      1.6419464 
ETK A      1.6305478 Levels not connected by same letter are significantly different. 
Ordered Differences Report 
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value  
ACK ETK 0.4124539 0.2180433 -0.162952 0.987860 0.2420  
ACK ETC 0.4010553 0.2432375 -0.240837 1.042947 0.3593  
ACK ACC 0.3957323 0.1945719 -0.117734 0.909198 0.1867  
ACC ETK 0.0167216 0.2200529 -0.563988 0.597431 0.9998  
ETC ETK 0.0113986 0.2640635 -0.685452 0.708250 1.0000  



















Keely Virginia O’Brien graduated Magna Cum Laude from the University of Tennessee 
at Chattanooga in 2007 earning a bachelor’s degree in biological sciences with a minor in 
chemistry.  At UTC Keely served as the president of the Biology Honor Society, Beta 
Beta Beta and was a member of several academic and service honor societies including 
Mortar Board and Greenspaces. In 2006 and 2007 she was awarded Outstanding 
Chemistry Laboratory Teaching Assistant.  After completing this degree Keely owned 
and operated a small business manufacturing cultured food products such as sauerkraut, 
kim chi, kombucha and kefir.  A passion for food and nutrition led to the study of 
fermented dairy products in the master’s program in The School of Animal Sciences at 
Louisiana State University.  She was awarded a Graduate Assistantship during her years 
of study at LSU and received her Masters Degree in 2012. When not studying or 
working, Keely enjoys spending time with her family, Jeff and Emily Fair, fermenting 
and cooking locally raised foods, outdoor activities and tending to her garden. 
 
 
 
 
 
 
 
 
 
	  
